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Abstract 
 
Introduction: Healthcare spending in Canada reached 219.1 billion dollars in 2015. Unnecessary 
laboratory test investigations have been well documented in many countries, making it an area of 
interest in order to reduce costs, improve care and ultimately improve the performance of the 
health care system. The use of serum urea is unnecessary to evaluate kidney function in stable 
patients as serum creatinine has better specificity and no decrease in sensitivity. Therefore, we 
examined the use of serum urea in the community of a regional health authority. Ferritin is a good 
test of iron status and indicated in anemic patients, particularly when mean corpuscular 
volume/mean corpuscular hemoglobin levels are low. Therefore, we examined the use of iron 
status tests in the community to determine the degree of under-utilization in the patients likely to 
have iron deficient anemia and of over-utilization in patients with normal hemoglobin and blood 
indices. 
 
 
Methods: We performed a retrospective analysis of Eastern Health’s laboratory electronic 
database to investigate patterns of laboratory test utilization for two specific bundles of tests: (1) 
serum creatinine and serum urea; (2) hemoglobin (hgB), ferritin and iron saturation. Laboratory 
tests were examined for a 6-month period in 2014 (bundle 1) and a 12-month period (bundle 2) 
throughout 2013-2014. Test utilization is described by age, sex, patient type (inpatient/outpatient), 
submitting physician specialty and test result. 
 
 
Results: 227, 092 serum creatinine and 218, 289 serum urea tests were ordered for all patients 
within the Eastern Health Region during the 6-month period. 96.8 % (n=211, 279) serum urea tests 
were ordered in the same draw as serum creatinine. 64.6% (n=141,112) serum urea tests were 
ordered in the same draw as serum creatinine for outpatients. General practitioners elicited the 
highest rate of serum urea tests (52.5% of total), followed by the internal medicine specialty.  
69.3% (n=62, 274) of coupled serum creatinine and serum urea laboratory investigations ordered 
by general practitioners for outpatients elicited normal results for both tests. High volumes of 
hemoglobin (n=450, 792) and iron status tests (ferritin; n=86,293, iron saturation; n=23,415) were 
ordered within the 12-month period. General practitioners elicited the highest ordering for all three 
tests for outpatients. 89.6% (n=55,595) of iron tests requested by general practitioners for non-
anemic outpatients (first Hgb) produced a normal result in the 12-month period. 44.9% (n=136) of 
females (≤ 50 years of age) with anemia did not undergo iron testing within 1-year of the first 
documentation of the anemia by a general practitioner. 
 
 
Conclusion: Serum urea and iron testing may be areas of interest for the improvement of 
utilization of health care resources within the Eastern Health Region. Information contained in this 
thesis may be used as a guiding tool for decision makers in the development of interventions to 
improve test-ordering behaviours without compromising patient quality of care.  
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Chapter 1: INTRODUCTION 
 
 Notable increases in health care expenditures have been reported in many countries	1-4. The 
Government of Newfoundland & Labrador’s expenditure on per person health care exceeded the 
Canadian average by 15.3% in 2015	4. Unnecessary utilization of laboratory resources has been 
reported in the literature, decreasing the quality of care provided to patients	5,6. Over testing may 
result in avoidable patient discomfort and an increase in the likelihood of false positive test results 
5,6. Under testing can cause delayed or missed diagnosis, creating a missed opportunity to improve 
patient outcomes	5.  Few interventions to reduce low value care undertook a laboratory resource 
focus	7. Laboratory testing is a focal point in many clinical decisions, emphasizing the need for 
investigations to identify low value care in specific clinical situations and interventions to modify 
unnecessary testing. In a recent collaborative effort, the Quality of Care program was developed, 
which is an academic initiative co-funded by the Government of Newfoundland and Labrador. The 
purpose of the Quality of Care program is to address unnecessary utilization of health care 
resources through research. The Quality of Care NL program works in conjunction with Choose 
Wisely Canada (CWC) to reduce unnecessary care, however, it is also their intent to ensure that 
the right patients receives the appropriate care at the right time through NL Specific Projects	8. The 
present study falls under the umbrella of this initiative. 
  
 
 
 
 
 2 
1.1 Purpose 
This project has been undertaken as we hypothesize that there will be a large number of 
potentially unnecessary serum urea tests ordered by general practitioners for outpatients. Similarly, 
we hypothesize that there will be both under and overutilization of iron tests. The findings from 
this assessment will be used to design and target interventions aimed at improving the 
appropriateness of utilization of these tests. The purpose of this investigation is to (i) identify the 
patterns utilization of renal function tests (serum urea, serum creatinine) during a 6-month period 
in 2014 (July 1st – December 31st) and iron status (iron saturation, ferritin) and hemoglobin tests 
during a 12-month period (April 1st, 2013 – April 1st, 2014) in the Eastern Health Region of 
Newfoundland (ii) Discuss approaches supported by the literature to decrease the inappropriate 
utilization of these laboratory tests and increase quality of care. At the time this work was done, 
we did not anticipate having the results of the implemented interventions. However, following the 
completion of my thesis work, decision makers have implemented interventions and analyzed the 
outcomes to date. Therefore, we will discuss the interventions that were undertaken and present 
the impact within the Eastern Health Region. 
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Chapter 2: LITERATURE REVIEW 
 
2.1 Search Strategy 
 
 A search was conducted through the National Library of Medicine using three databases: 
Medline, Embase and Cochrane Libraries with search terms pertinent to studies investigating the 
unnecessary utilization of health care resources, clinical laboratory tests, and the interventions 
undertaken to reduce the utilization of health care resources. Where applicable, inclusive initial 
searches were conducted to identify MeSH terms for more specific and exhaustive investigations 
of the literature. Bibliographies of relevant articles were also reviewed. 
 Restrictions of the literature search included: English articles only, abstract availability and 
humans only. The literature search was not restricted by date to ensure that that review would give 
a complete overview of the literature surrounding the unnecessary utilization of health care 
resources and the progress made in the effective development and implementation of interventions. 
 This literature review will offer background information of health care resource utilization 
in Canada, information on the contribution of laboratory testing to the increase in Health care 
expenditures and interventions undertaken to reduce the overutilization of laboratory testing. 
Additionally, this review will discuss the initiatives developed internationally, nationally and 
provincially to minimize the utilization of healthcare resources. 
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2.2 Background Information  
 
 Healthcare spending has increased over the past several decades and is projected to 
continue its’ rise for a variety of reasons including an ageing population and an increase in the 
incidence of obesity	1-3. This increase has been noted in many countries and emphasizes the 
necessity to develop a more efficient health care system. In 2015, healthcare spending in Canada 
reached 219.1 billion dollars	4. This expenditure represents 10.96 percent of the Gross Domestic 
Product (GDP) and a 4 billion dollar (1.6%) increase in comparison to 2014	4. More than 60% of 
Canada’s total health care dollars are being spent in three areas. These areas consist of hospitals 
(29.5%), drugs (15.7%) and physician services (15.5%)	4. In 2015, the government of 
Newfoundland & Labrador spent  $7,036 (40% of the budget) per person on health care	4. This 
expenditure is $931 (15.3%) greater than the Canadian average ($6,105)	4.  This is higher than any 
other province for per person health care expenditure in Canada, excluding the North West 
Territories, Nunavut & Yukon. 
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2.3 Laboratory Testing 
 
Laboratory testing is a prominent medical activity and is integral to many clinical 
decisions. It has been documented that there is a high incidence of inappropriate laboratory 
utilization	5. This unnecessary utilization is accompanied by an increase in cost and a decrease in 
quality of care	6. Over utilization of laboratory testing causes unnecessary blood draws and an 
increase in procedures associated with sample collection	5. This unneeded testing increases the 
likelihood of generating false positive test results, elevating the risk of incorrect diagnosis which 
in turn can increase costs and produce adverse outcomes associated with unwarranted 
interventions  5,6.  False positive test results also have the potential to increase patient worry 
unnecessarily. Under testing has the potential to result in a delay or missed diagnosis, creating 
further implications for the patient and healthcare system downstream	5,6. The result of both under 
and over utilization of these clinical investigations is a decrease in the quality of care provided to 
patients. Laboratory testing is an obvious area of interest to implement interventions to decrease 
inappropriate utilization; some studies have noted that the proportion of inappropriate tests range 
from 4.5-95%	6. Identifying and rectifying inappropriate of laboratory resources is of paramount 
importance in order to optimize patient care and improve the performance of the health care 
system	6. 
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2.4 Interventions to Reduce Laboratory Testing 
 
Recently, a systematic review was performed to investigate the effectiveness of varying 
types of interventions to reduce low-value care	7. In this review, while complex to define, the term 
low-value care involved the use of care that was not likely to be beneficial to the patient, given the 
cost, available alternatives and the preferences of the patient.  Colla and colleagues	7 strived to 
exclude interventions directed at reducing general utilization from efforts aimed at specific low 
value or inappropriate services. The authors divided all interventions into two categories: (1) 
Demand side interventions (patient demand for care), (2) Supply side interventions (Provider 
supply of care). Demand side interventions included: Patient cost sharing, Patient education, 
Provider Report Cards (giving patients information on the providers use of inappropriate care 
with the intent of altering behaviour as a result). Supply-Side interventions included: Pay-for-
performance, Insurer restrictions, Risk sharing, Clinical decision support, Clinician education, 
Provider feedback	7. The systematic review revealed that multifaceted interventions, which address 
both the patient and providers roles in overuse, have the greatest potential to reduce the use of low-
value care	7. Performance feedback and clinical decision support were also found to be effective 
strategies and clinician education was also found to elicit change when coupled with other 
interventions	7. Colla and colleagues	7 found that the interventions implemented to reduce low-
value care were most common for medications (56%), followed by radiology (12%), procedures 
(10%) and labs/pathology (10%), emphasizing the need for a increase of investigations of 
interventions to reduce laboratory test utilization specifically for tests that provide low value care 
in clearly defined clinical situations. 
Kobewka and colleagues	9 recently conducted a systematic review which specifically 
investigates the effectiveness of interventions to reduce laboratory test utilization by physicians. 
 7 
Interventions were classified into four categories: (1) Educational, (2) Audit and Feedback, (3) 
System-based and (4) Incentive or Penalty Interventions. Educational interventions consisted of 
appropriate test ordering being taught to physicians (distribution of guidelines). Audit and 
feedback interventions occurred when physicians were given their test utilization in comparison to 
their previous utilization or peer utilization (or could include total costs of their test ordering 
behaviour).  System-based interventions consisted of a one-time, permanent change to the test 
ordering process (ordering form modifications, computer order entry systems with restrictions or 
guidelines). Finally, Incentive or Penalty interventions were defined as physicians receiving 
punishments or rewards for particular test ordering behaviours	9. The review found that 
educational interventions had the highest relative reduction in laboratory test utilization, however, 
the sustainability of this type of intervention is questioned due to the minimal follow-up periods 
used throughout the literature	9. In addition, it was noted that interventions with multiple strategies 
and interventions that targeted less than four tests were more effective	9. The sample population, 
intervention, study design, recorded measurements and setting varied immensely across almost all 
studies. This high level of heterogeneity throughout the literature generates difficulty in 
interpreting which type of intervention is most effective and if the results are generalizable to other 
geographical locations and populations	9. 
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2.4.1 Quality of Care NL 
 
The Quality of Care Newfoundland and Labrador is an initiative within Memorial 
University of Newfoundland that has developed a partnership with other organizations including 
Department of Health and Community Services (DOHCS), Newfoundland & Labrador Centre for 
Health Information (NLCHI), Regional Health Authorities (RHAs) and Newfoundland & 
Labrador Medical Association (NLMA). These together make up a working group that oversees 
the Quality of Care program. The primary purpose of the Quality of Care program is to identify the 
right patient who needs the right intervention at the right time and address unnecessary utilization 
of health care resources. This program is directly supported by the Center for Health Information 
and Analytics (CHIA). CHIA facilitates research for improving patient outcomes through the use 
of high-performance health informatics and data analytics hardware and will enable the integration 
of complex data from multiple partner sources	10. The Quality of Care program is comprised of 
several areas of research: Laboratory Utilization, Diagnostic Imaging, Long-Term Care, Provincial 
Disease Management Program, Drug Utilization, Coronary Revascularization and Bariatric 
Surgery. The Quality of Care division is the parent program, which partakes in Newfoundland 
specific projects in addition to an implementation program associated with Choosing Wisely 
Canada (CWC) (See Figure 1: Quality of Care Cascade). Quality of Care NL works in close 
proximity to CWC in order to implement their recommendations on reducing unnecessary care. It 
is important to highlight that Quality of Care NL’s intent is not only to reduce unnecessary care, it 
is also the initiative’s intent to discover new ways to find who needs care, recommend the 
appropriate times that testing should occur and ultimately ensure that the right treatment is given 
to the right patient at the right time	8.  There are several projects that fall under the arm of this 
initiative, two of which are the centerpiece of this thesis: (1) Serum Urea & Serum Creatinine, (2) 
 9 
Hemoglobin & Iron testing. These topics will be discussed in further detail in the sections 
allocated to their descriptions. 
 
 
Figure 1: Quality of Care Cascade 
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2.4.2 Choosing Wisely  
 
 Choosing Wisely is an initiative created by the American Board of Internal Medicine 
(ABIM)	11. This initiative was formally launched in April 2012, with its goals oriented at 
promoting conversations between clinicians and patients by aiding patients to make informed 
choices while choosing care. The organization’s mission is to facilitate care that is: (1) supported 
by evidence, (2) free from harm, (3) truly necessary, (4) not duplicative of other tests or 
procedures already received	11. Initially, the organization released a “top five” list in adjunct to 
their campaign launch. This list consisted of five tests and treatments from nine specialty societies 
that were overused and did not provide meaningful benefit to their patients. Due to a positive 
reaction from the health care community and media coverage, 17 additional societies joined the 
campaign and released lists in February of 2013. Currently, there are more than 70 medical 
societies, comprised of over one million physicians, who are now partners with the Choosing 
Wisely Campaign. To date, the organization has collectively published over 450 recommendations 
about unnecessary tests and treatments.  This campaign has developed partnerships, drawn media 
interest, inspired research, catalyzing the improvement of care	11. 
 
2.4.3 Choosing Wisely Canada (CWC) 
 
  The Choosing Wisely Canada (CWC) campaign is modelled after the Choosing Wisely 
organization in the United States of America	12. The CWC campaign began in Ontario and quickly 
sparked the interest of other provinces. To date, all provincial and territorial medical associations 
have endorsed the campaign and have either established or are in the process of establishing their 
own provincial/territorial initiative. Choosing Wisely Canada has been working with Medical 
schools across the country to introduce new content into undergraduate, post- graduate and 
 11 
continuing medical education curricula. In addition, they have made an active effort to engage 
medical students by launching the STARS program (Students and Trainees Advocating for 
Resource Stewardship)	12. Through the collaborations of various health organizations and 
associations, opportunities have developed to help support the implementations of physician 
recommendations in practice settings. They have introduced an “early adopters collaborative” to 
bring such groups together. The CWC campaign has invited these early adopters to participate in 
the 10 million challenge; a Canada wide call to action initiative to aid in the prevention of ten 
million unnecessary tests and treatments by the year 2020	12. 
 
2.4.4 Choosing Wisely NL 
 
 Choosing Wisely NL is the Newfoundland & Labrador provincial chapter of the Choosing 
Wisely Canada campaign. Choosing Wisely NL was launched October 6th, 2016. This provincial 
campaign is a collaborative effort between: The Translational and Personalized Medical Initiative 
(TPMI), The Newfoundland & Labrador Medical Association (NLMA), the provincial 
government, regional health authorities, patients and the Newfoundland & Labrador Centre of 
Health Information (NLCHI)	13. The creation of Choosing Wisely NL emerged from research 
being conducted at the Faulty of Medicine of Memorial University	14. Various stakeholders 
collaborated to develop a program similar to Choosing Wisely Canada (CWC)	12 and its American 
equivalent	11. The desired outcome of the Choosing Wisely NL program is to be an available 
resource to provide recommendations to health care professionals and the public of Newfoundland 
and Labrador concerning the appropriate use of tests and procedures	14. Choosing Wisely NL is a 
regional affiliate of Choosing Wisely Canada and is bound by their policies. Therefore, CWNL 
projects are focused on decreasing low value care while implementing recommendations of CWC. 
 12 
All other projects that do not follow CWC recommendations are classified as Quality of Care 
projects. 
 
 
2.4.5 Interventions to Reduce Laboratory Testing in Primary Care settings 
 
 
This sub-category of the literature review is concerned with obtaining a complete overview 
of all interventions undertaken in primary care settings to reduce laboratory test utilization. 
Therefore, an exhaustive search strategy was utilized. The search strategy is as follows: 
 The literature search was conducted using three databases: Pubmed, Embase and Cochrane 
Libraries.  The Pubmed database was searched from 1950-2015 by combining Mesh terms of 
relevant articles. These Mesh search terms consisted of: “Primary Health Care AND Clinical 
Laboratory Services/utilization OR Clinical Laboratory techniques/utilization OR Diagnostic 
Tests, Routine/utilization OR Health Services Misuse/prevention and control OR Unnecessary 
Procedures/utilization AND Utilization review”.  Search results were filtered to include only 
articles with abstracts, human subjects and restricted to the English language. The same search 
restrictions and key terms were applied while searching the other data sources (Embase & 
Cochrane Libraries). Searches were augmented and enhanced by scanning the bibliographies of 
included articles as well as relevant review articles. The literature search elicited nineteen articles 
that specifically investigated the effectiveness of interventions undertaken in a primary care setting 
to reduce laboratory test utilization and met the following criteria: 1.) The study had to focus on 
primary care (general practice physicians) or have a sub-category which focused on general 
practice physicians; 2.) The aim of the intervention was to modify test utilization (ordering/cost / 
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tests performed; 3.) A control (comparator) was required (either a no-intervention group or 
standard care). 
 Using a non-experimental, before-after study design, Larson and colleagues	15 investigated 
the effects of an education program on 63 primary care physicians at 19 primary care centres in 
Sweden. The intervention involved a 2-day educational series. The investigators used the 
physician’s current practice (historical control) as a comparator. Of the 7 test ratios (e.g. 
Cholesterol / HDL Cholesterol) that the educational series recommended to decrease, 5 did 
significantly (p <0.05)	15. Additionally, 7 ratios were recommended to increase in ordering 
volume, 4 of which did (p <0.05)	15.  
 
Similarly, Baricchi and colleagues	16 investigated the effect of an educational intervention 
which involved 8 training sessions for pathology specific laboratory profiles that were developed 
by a multidisciplinary inter-hospital team. The investigators reported that there was a 5% reduction 
in the number of tests requested by the intervention group (n=23) (p < 0.001) one year following 
the intervention	16. The authors also highlighted there was a significant decrease in the volume of 
tests on each request form in the intervention district (8.73 VS. 10.77; p< 0.001).  
 
Rhyne and colleagues	17 also used a before-after study design to explore the effect of an 
educational intervention on all thyroid function panel tests ordered by physicians in the Duke-
Watts Family Medicine Program. The authors performed an audit on all thyroid function panel 
tests performed during a 6-month period, then presented the results of the audit at an educational 
conference	17. A re-audit was performed 6-months following the educational conference. The 
authors reported that the rate of ordering during the initial 3-months following the intervention 
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decreased significantly (p<0.05), however, the rate returned to the pre-intervention level in the 
final 3-months post-intervention	17. As previously highlighted, the sustainability of educational 
interventions is brought into question due to the short follow-up periods used throughout the 
literature	9. These investigations 	15-17 provide support for this query.  
 
However, Mindemarke and colleagues	18 conducted an extension of the trial by Larsson 
and colleagues	15 to investigate the long-term effects of an educational program on test ordering 
behaviours. The test ordering behaviours of 23 physicians were monitored in 2004 and compared 
to their ordering behaviours in 1997 (8-years post intervention follow-up)	18. Eleven of the twelve 
investigated ratios were the same or had improved since the short- follow up period	15,18. These 
results provide minimal evidence that continuing education intervention programs have the ability 
to elicit long lasting, permanent changes in test ordering. 
 
 Several trials have used multifaceted interventions, which have included an educational 
component	19-23. Abdel-Kader and colleagues	21 performed a Randomized Controlled Trial on 30 
Primary Care Physicians to evaluate the effectiveness of an educational & guidelines intervention 
to enhance the appropriateness of referrals to a specialist. The trial involved both the intervention 
arm (n=15) and the control arm (n=15) attending two Chronic Kidney Disease Educational 
sessions while the intervention group also received real time, automated, electronic medical alerts 
for renal referral	21. The control group did not use the guideline alert system. The trial consisted of 
a 6-month post-intervention follow-up period and the authors reported no significant differences 
between groups (volume of renal referrals)	21.  
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Thomas and colleagues	23 also used a Cluster Randomized Controlled trial design to 
implement an education and feedback intervention on 370 primary care physicians (85 primary 
care practices). The practices were randomly assigned to 1 of 4 arms: (1) reminder messages (n=22 
practices), (2) control practices (n=20 practices), (3) enhanced feedback (n=22 practices), (4) both 
enhanced feedback and reminder messages (n=21 practices)	23. The intervention consisted of 
quarterly feedback of practice requesting rates for nine laboratory tests, supplemented with 
educational messages and brief educational reminders	23. The results showed an 11% reduction for 
practices receiving either feedback or reminder messages compared with the control group and a 
greater than 20% reduction in tests for groups that received combined interventions 23. The authors 
suggest that these results highlight that feedback and education reminders are feasible 
interventions to reduce laboratory test utilization alone or in combination	23.  
 
Similarly, an investigation conducted by Bunting et colleagues	22 used an education and 
feedback intervention in an attempt to reduce laboratory test utilization. Physicians in the 
intervention group (n=100) were visited three times by laboratory representatives over a 2-year 
period	22. Each visitation consisted of an educational presentation and the physicians personalized 
laboratory test utilization data; this personalized data was also compared to the utilization data of 
the physicians’ peers	22. The test utilization rates were measured 1-year pre-intervention, during 
the intervention period and 2 years after the intervention. The authors used a time series analysis 
and reported a significant decrease in laboratory utilization in the intervention group compared to 
the control group for the 2-years post intervention (-7.9%; p <0.0001)	22.  
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Tierney and colleagues	19 used a divergent approach to investigate an educational and 
feedback intervention. In contrast to other studies, the intervention consisted of providing 
information on the test ordering of the physicians based on cost. Physicians in both the 
intervention (n=62) and control (n=59) groups entered their orders for tests through computer 
workstations, the intervention group were displayed the charge of the individual test being ordered 
and the total charge for each patient, the control group would receive no feedback	19. The 
intervention was undertaken for a 26-week period and during this time physicians ordered 14% 
fewer tests per patient visit compared to the control group (p < 0.005). The post-intervention 
period endured for 19-weeks, in which the authors noted that the intervention group ordered only 
7.7% fewer tests compared to the control group	19.  
 
Finally, Verstappen and colleagues	20 used an intervention which combined education, 
guidelines and feedback strategies. Their investigation involved 194 Primary Care physicians that 
were randomly allocated into two groups. A test ordering strategy was developed involving 
feedback, education on guidelines and quality improvement sessions in small groups. In these 
groups physicians were required to discuss each other’s test ordering behaviours related to the 
guidelines and make individual and group plans for change	20. Thirteen groups of physicians were 
engaged in the entire strategy whereas fourteen groups received only the feedback component of 
the intervention	20. Verstappen and colleagues	20 found that the mean cost reduction in the 
complete intervention arm (n=13) was 144 euros larger per physician per 6-months in comparison 
to the physicians in the feedback only arm (n=14) (p=0.0048)	20.  
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Studies which have used clinical guidelines and/or feedback as a crucial component of their 
intervention have had varied success	24-27. Baker and colleagues	24 conducted a randomized 
controlled trial and implemented an intervention where physicians in one group (n=50) received 
guidelines and feedback on test ordering behaviours for thyroid function, rheumatoid factor testing 
and urine cultures. Physicians in the second group (n=38) received guidelines and feedback for 
their test ordering behaviours of lipid and plasma viscosity tests	24.  Intervention was implemented 
quarterly over a 12-month period with measurements being recorded at each stage	24. Baker et 
colleagues	24 reported no significant change in the volume of tests per 1000 requested in either 
branch of the study groups, or for any individual test.  
 
Van Wijk and colleagues	25 were successful at demonstrating the effectiveness of 
guidelines integrated into an electronic ordering system. In this randomized controlled trial two 
versions of BloodLink (computer-based support system) were developed: (1) BloodLink 
Restricted, (2) BloodLink Guidelines 	25. The restricted system initially displayed a reduced list of 
tests (15 tests found to cover most clinical scenarios seen in primary care) in addition to providing 
an option for physicians to select other tests. The guideline system displayed test-ordering 
guidelines from the Dutch College of General Practitioners to assist in decision-making and test 
ordering. The authors found that a decision support system based on guidelines was more effective 
in changing blood test ordering behaviours than a system based initially on a restricted order form	
25. Physicians who utilized BloodLink Guidelines on average requested 20% fewer tests compared 
to physicians using BloodLink Restricted	25.  
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Similarly, Vardy and colleagues	26 demonstrated that a collection of laboratory routines 
developed by a group of experienced and certified physicians and integrated in a computerized 
ordering system were able to elicit a decrease in laboratory test utilization (-2%; no statistical 
parameters provided). However, this is a weak result and may be due to chance. 
 
Although the literature emphasizes that effectiveness of multifaceted interventions	7,9,28 
,Winkens and colleagues	27 demonstrated that an intervention composed of only feedback in the 
form of biannual reports of test ordering behaviours was able to elicit a significant decrease (p 
<0.001) in utilization patterns.  
 
Interventions that are classified as system based were particularly effective at reducing 
laboratory test utilization in primary care settings. These system-based interventions all consisted 
of developing and implementing various changes to the laboratory test order form	29-34.  Emerson 
and colleagues29 implemented a requisition form that was limited to Medicare approved panels. In 
addition, forms were also customized based on groups of specialties and patient service location 
with common test ordering practices. The authors reported that all specialities showed a significant 
reduction in laboratory utilization (p<0.001) excluding Neurology & AIDS (significant increase) 
and Urology, Orthopaedics & G.I. service (no significant change)	29.  
 
A study conducted by Kahan and colleagues	31 implemented a new version of a 
computerised order form and the volume of tests ordered in the initial month for the three target 
tests decreased 31-41% relative to the pre-intervention month and decreased 36 -58% the 
following month. Another study implemented a changing order form intervention by incorporating 
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the cost of 27 laboratory tests within an electronic health record	30. The cost display system 
resulted in a significant decrease in laboratory orders per 1000 visits per month (p<0.001)	30.   
 
Another form of a change in order form intervention throughout the literature is the 
implementation of restricted order forms. Shalev and colleagues	33 modified the regional health 
order form into a more restricted version, rendering the number of tests on the order form with a 
check box reduced from 51 to 26 tests. The authors reported that the tests that were removed 
elicited a 27% reduction in the first 12 months and a 19.2% reduction in the second year following 
the implementation of the new restricted form	33.  
 
Similarly, Zaat and colleagues	34 implemented a restricted order form to a group of 
physicians (n=28) and compared their test ordering behaviours to a control group who used the 
standard ordering form (n=28). The form was modified so that if the test was not present, the 
physician would write a hand-written request. The intervention elicited an 18% reduction in the 
number of tests ordered per general practitioner, per 1000 patients, per month during the 
intervention period	34. An emphasized issue with restricted order forms is that they have the ability 
to limit appropriate test requests.  
 
A study conducted by Meng and colleagues	32 took this into consideration while 
developing a Cardiac Troponin algorithm to limit orders from outpatient clinics while maintaining 
ordering abilities for emergency departments. General practitioners were still able to order 
troponin tests following a consultation with a clinical biochemist. This order form restriction 
intervention elicited a significant reduction in the number of requests for the Cardiac troponin tests 
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from Family medicine clinics (n=1, 213(6.4% of all tests requested) to n=355 (2.7% of all tests 
requested), p=0.003)	32.  
 
Similar to other interventions, the sustainability of the restricted order form impact has 
been challenged. Meng and colleagues	32 and Shalev and colleagues	33 used relatively short follow 
up periods, 6 months and 24 months respectively. Zaat and colleagues	34 successfully reduced 
laboratory test utilization during the intervention period, however, the authors noted that following 
the removal of the restricted order form intervention the ordering behaviours returned to their pre-
intervention patterns. 
 
There have been very few studies conducted which specifically investigate the effect of 
interventions undertaken in primary care settings to reduce laboratory utilization and only a 
handful are of good quality.  The majority of these studies have been conducted using an 
uncontrolled before-after design, which is inherently a methodologically weak study design. 
Another major limitation of the current literature is the generalizability of the results. The sample 
population, intervention, design, recorded measurements and setting varied immensely across 
almost all studies. This high level of heterogeneity throughout the literature generates difficulty in 
interpreting which type of intervention is most effective in primary care settings and if the results 
are generalizable to other geographical locations and populations. 
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    Table 1: Tabularized Overview of Interventions Undertaken in Primary Care Settings 
 
 
Study Location Design Population Method	 Intervention Control Follow-up Outcome
Abdel-Kader	et	al USA Cluster	Randomized	Controlled	Trial 30	Primary	Care	Physicians Education	&	Guidelines Two	Chronic	Kidney	
Disease	Educational	
Sessions	were	held	for	
primary	care	physicians	
in	both	arms.	
Intervention	Group	(15	
physicians)	also	
received	real	time	
automated	electronic	
medical	record	alerts	
for	renal	referral.
Control	Group	
did	not	use	the	
CDSS	alert	
system
6-	months	pre-
intervention	&	
6-months	post-
intervention
No	significant	
differences	between	
groups	(Renal	
Referals)
Baker	et	al UK Randomized	Controlled	Trial 33	General	Practices	(96	
practitioners)
Guidelines	&	Feedback 17	practices	(50	Gp's)	
received	guidelines	
followed	by	feedback	
on	test	ordering	
behaviours	for	thyroid	
function,	rheumatoid	
factor	test	and	urine	
cultures	they	ordered	(3	
month	Intervals	during	
a	12	month	period)
16	practices	(38	
Gp's)	received	
guidelines	&	
feedback	for	
for	lipid	and	
plasma	vicosity	
tests.																								
Each	group	
experimental	
arm	was	a	
control	for	the	
other)
Baseline	-	12	
months	with	
quarterly	
feedback	and	
measurements
No	significant	
change	in	volume	of	
tests	per	1000	
requested	in	either	
arm	of	the	study	
groups	or	for	any	
specific	test.
Baricchi	et	al Italy Observational	study	with	two	
retrospective	audits
44	Primary	Care	physicians Education	 Mutidiscplinary	inter-
hospital	team	
developed	pathology	
specific	laboratory	
profiles	for	more	
effectice	test	requesting	
and	provided	8	training	
sessions	to	physicians	
about	their	use	(n=23	
physicians)
21	General	
practitioners	
from	a	different	
district.The	
laboratory	tests	
for	both	
districts	are	
performed	at	
the	same	
laboratory	
(current	
practice)
12	-	Months	pre-
and	12	months	
post-
intervention.							
Thirty	days	
were	randomly	
selected	over	
the	course	of	
each	period	and	
the	total	
number	of	test	
requests	forms	
and	the	total	
number	of	
ordered	tests	
were	recorded.
Number	of	tests	
requested	in	the	trial	
district	was	
significantly	lower	
than	the	previous	
year	(5%;	p	<0.001)						
-Significant	decrease	
in	the	number	of	
tests	on	each	
request	form	in	the	
trial	district	(8.73	VS.	
10.77;	p	<0.001)
Bunting	et	al Canada Time-Series	Analysis 200	Primary	Care	Physicians Education	&	Feedback Intervention	physicians	
(n=100)	were	visited	up	
to	three	times	by	
laboratory	
representatives	over	a	2-
year	period.	At	each	
visit	the	laboratory	
representatives	
presented	educational	
material	and	the	
physicians	personalized	
laboratory	test	
utlization	data.	This	
personalized	data	was	
also	compared	to	the	
physicians	peers.
No	information	
or	personalized	
feedback	given	
to	the	control	
group	(n=100)
2	years	post	
intervention
Laboratory	
utilization	decreased	
significantly	in	the	
intervention	goup	
compared	to	the	
control	group	for	the	
2	years	after	the	
intervention	ended.	
Reduced	by	7.9%	(p	
<0.0001)
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Emerson	et	al USA Non-Randomized	Controlled	Trial Family	physicians	and	
residents	in	outpatient	
locations
Changing	Order	Form Rquisition	forms	limited	
to	Medicare	approved	
panels.	Using	baseline	
date,	requisition	forms	
were	also	customized	to	
groups	of	specialities	
and	patient	service	
locations	with	common	
ordering	practices.	
Several	cascades	were	
implemented/emphasiz
ed	in	order	to	ensure	
the	medical	necessity	of	
tests	while	decreasing	
diagnosis	time	and	
increasing	convenience	
for	patient/physician.					
The	requistions	were	in	
place	for	6-months	
before	follow-up	data	
collection	began.
Current	
practice:	
Number	of	all	
laboratory	tests	
ordered	by	
physicians	in	
each	outpatient	
location	was	
retrieved	from	
the		laboratory	
information	
system	for	a	
period	of	6-
months.
7-Months	post	
intervention
All	specialties	
showed	a	singificant	
reudction	in	
laboratory	utilization	
(	p	<	0.01)	excluding	
Neurology	&	Aids	
(significant	increase)	
and	G.I	service,	
Urology	&	
Orthopedics	(No	
significant	change)
Horn	et	al USA Interrupted	Time	Series 215	Primary	Care	Physicians Changing	Order	Forms Cost	display	of	27	
laboratory	tests	was	
displayed	within	an	
electronic	health	record	
(n=153)
No	cost	display	
within	health	
record	(n=62)
12	months	pre-
intervention	
and	6-months	
post-
intervention.	In	
addition,	
surveyed	
physicians	from	
both	arms	6-
months	post	
intervention	to	
assess	attitudes	
regarding	
costs/cost	
displays.
Cost	display	
intervention	resulted	
in	a	reduction	of	0.4-
5.6	laboratory	
orderes	per	1000	
visists	per	month	
(p<0.001)
Kahan	et	al Isreal Non-Randomized	Controlled	Trial,	
Before-after	design
Primary	Care	Physicians Changing	Order	Form A	new	version	of	a	
computerized	order	
form	was	launched.	
Number	of	B12,	folic	
acid	and	ferritin	was	
calculated	for	the	
intervention	group
Controls	were	
the	utilization	
patterns	of	
laboratory	tests	
for	HgB	and	
Iron	during	this	
period,	as	their	
presentation	on	
the	form	was	
not	affected	by	
the	new	
format.	Curren	
Practice.
6-months	pre-
intervention	
and	4-months	
post	
intervention
The	first	post-
intervention	month	
elicited	a	decrease	of	
31%	-	41%	relative	to	
the	pre-intervention	
month	and	a	36%-
58%	reduction	the	
following	month.	
There	was	a	2%	-	3%	
change	for	controls
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Larsson	et	al Sweden Before	-	After	design 63	Primary	Care	Physicians	
at	19	primary	care	centres.
Education 2-	day	educational	
lecture	series,	all	
recommendations	were	
supported	by	
references	from	
scientific	litterature.	
These	individuals	were	
informed	that	their	
ordering	habits	would	
be	monitored
Current	
Practice,	
Historical	
Control	pre-
intevention
8-months	pre-
intervention	
and	4-months	
post-
intervention
Of	the	7	ratios	that	
were	recommended	
to	decrease	in	
volume,	5	did	
significantly	(	
p<0.05).	Of	the	7	
ratios	that	were	
recommended	to	
increase,	4	did	
significantly	(p	<	
0.05)
Meng	et	al Canada Before	-	After	Design All	3	Tertiary	hospitals	and	
outpatient	clinicis	in	this	
region
Order	form	restrictions A	cardiac	Troponin	test	
algorithm	was	
developed	by	a	group	of	
cardiologists,	physicians	
and	laboratory	
professionals.	Its	
purpose	was	to	limit	
orders	from	outpatient	
clinics	and	non-
emergency	
departments	while	
maintaining	order	
priority	for	cardiac	care	
units,	intensive	care	
units	and	trauma	care	
units.	Family	physicians	
could	still	order	the	
troponin	tests	following	
a	consultation	with	a	
clinical	biochemist.
Current	
practice,	
historical	
control,	6-
months	pre	
intervention
6-months	post	
implementaion	
of	the	cTnI	test	
algorithm
Total	number	of	test	
requests,	the	
number	of	
requestions	from	
outpatient	clinics	
and	other	locations,	
third	consecutive	
requestsa	and	more	
than	3	requests	per	
patient	reduced	
significantly.	
Specifically,	the	
number	of	requests	
for	family	medicine	
reduced	significantly	
from	1,	213	(6.4%)	to	
355	(2.7%),	
(p=0.003)
Mindemarke	et	al Sweden Before-after	design 23	Primary	care	physicians	
at	16	primary	health	care	
centres
Education No	intervention,	the	
study	is	a	continuation	
of	the	study	conducted	
by	Larsson	et	al,	to	
investigate	the	long-
term	effects	of	an	
educational	programme	
Historical	
control	group,	
The	test	
ordering	
behaciours	of	
23	physicians	
were	
monitored	in	
2004	and	
compared	to	
their	ordering	
behaviours	in	
1997.Subjects	
were	told	that	
follouw-ups	
would	take	
place
8-years	post	
intervention	
follow-up
11/12	of	the	
investigated	ratios	
were	the	same	or	
had	improved	since	
the	time	of	the	short	
follow-up	period	(6-
months).	These	
results	suggest	that	
continuing	education	
programs	can	bring	
about	long	lasting	
changes	in	test	
ordering.
 24 
Table 1: Tabularized Overview of Interventions Undertaken in Primary Care Settings 
 
 
Rhyne	et	al USA Before-after	design All	Thyroid	function	panel	
tests	ordered	by	physicians	
in	the	Duke-Watts	Family	
Medicine	Program
Education Audit	was	performed	on	
all	Thyroid	function	
panels	performed	
during	a	6-month	
period.	Survey	was	
developped	from	the	
audit	to	determine	how	
"essential	to	goo	
medical	care"	the	
practice	members	
considered	the	TFP	in	
the	evaluation	of	the	10	
common	problems	
identified	in	the	audit.	
To	complete	the	
education,	the	results	of	
the	audit,	and	the	
survey	were	presented	
at	a	conference.	The	
conference	focused	on	
the	process	of	clinical	
decision	making,	hoping	
physicians	would	gain	
awareness	of	factors	
that	effect	test	ordering	
behavior.
Current	
practice,	
historical	
control
re-audit	was	
performed	6-
months	post	
educational	
intervention
During	the	6-month	
post	intervention	
period,	the	rate	of	
ordering	during	the	
first	three	months	
decreased	
significantly	(	p	
<0.05).	However,	the	
ordering	rate	rose	to	
the	pre-intervention	
level	in	the	
subsequent	3-
months	of	the	follow-
up	period.
Shalev	et	al Isreal Non-experimental,	descriptive	
study	design
865	Primary	Care	Physicians Change	in	ordering	
form
Altering	the	order	form	
into	a	more	restricted	
version.	The	volume	of	
tests	on	order	form	
available	using	a	check	
box	reduced	from	51	to	
26	
Current	
practice	(form)	
prior	to	
intervention	
12	months	pre-
intervention	
and	24	months	
post-
intervention
The	tests	that	were	
removed	elicited	a	
27%	reduction	in	the	
first	year	and	19.2%	
reduction	in	the	
second	year	
following	the	
implementation	of	
the	restricted	order	
form
Thomas	et	al UK Randomized	Controlled	Trial 370	Primary	Care	Physicians	
(33	practices)
Education	and	
Feedback
Quarterly	feedback	of	
practice	requesting	
rates	for	nine	
laboratory	tests,	
enhanced	with	
educational	messages	
and	brief	educational	
reminders.	The	
practices	were	assigned	
to	1	of	4	arms:	reminder	
messages	(22	practices),	
control	(20	practices),	
enhanced	feedback	(22	
practices),	both	
enhanced	feedback	and	
reminder	messages	(21	
practices)
Control	group	
consisting	of	20	
practices,	
current	practice
12-months	pre-
intervention	
and	12-months	
post	
intervention
11%	reduction	in	
requests	for	
practices	receiving	
feedback	or	
reminder	messages	
compared	with	
control	group.	Both	
in	combination	or	
alone	are	feasible	
methods	for	
reducing	test	
requesting	in	
primary	care	
settings.
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Tierney	et	al USA Randominzed	Controlled	Trial 121	primary	care	physicians	
(4	practices)	in	the	
Regenstrief	Health	Center
Education	and	
Feedback
The	intervention	group	
(n=62),	the	charge	of	
the	test	being	ordered	
and	the	total	charge	of	
tests	for	that	patient	on	
that	day	were	
displayed.	The	
intervention	perfiod	
was	undertaken	for	a	26	
week	period.
Control	Group	
(n=59)	no	
feedback	given
14	weeks	pre-
intervention	
and	19	week	
post-
intervention	
During	the	
intevention	period,	
the	physicians	
ordered	14%	fewer	
tests	per	patient	visit	
compared	to	the	
control	group	(	p	
<0.005).	During	the	
post-intervention	
period,	the	
intervention	group	
ordered	7.7%	fewer	
tests	compared	to	
the	control	group.
Van	Wijk	et	al Netherlands Randomized	Controlled	Trial 60	Primary	Care	Physicians	
from	44	practices
Guidelines	using	
electronic	ordering	
system
Two	versions	of	
BloodLink,	which	is	a	
computer	based	
support	system	were	
developed.	BloodLink	
Restricted	initially	
displays	a	reduced	list	
of	tests	and	BloodLink-
Guideline	is	based	on	
guidelines	of	the	Dutch	
College	of	General	
Practitioners
Each	group	
acted	as	a	
control	for	the	
other
Study	Period:	
July	1,	1994	-	
June	1995
Decision	support	
based	on	guidelines	
is	more	effective	in	
changing	blood	test-
ordering	behavior	
than	decision	
support	that	is	based	
on	initially	
desplaying	a	
restricted	number	of	
tests.	General	
practitioners	who	
used	BloodLink	
Guidelines	requested	
20%	fewer	tests	on	
average	compared	to	
physicians	using	
BloodLink	Restricted
Vardy	et	al Isreal Non-Randomized	Controlled	Trial 380	Primary	Care	Physicians Guidelines Conscensus	group	of	
experienced	and	
certified	physicians	was	
formed	in	order	to	
develop	a	compendium	
of	laboratory	routines.	
The	computerized	
laboratory	routines	
were	organized	into	
tests	for	screening,	tests	
to	assess	the	extend	of	
the	problem	and	full	
evaluation.
Historical	
control	group
3-months	post	
intervention
2%	decrease	in	
laboratory	tests	
ordered	in	2004	
(1,792,221)	
compared	to	2003	
(1,834,366)
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Table 1: Tabularized Overview of Interventions Undertaken in Primary Care Settings 
 
Verstappen	et	al Netherlands Randomized	Controlled	Trial 194	Primary	Care	Physicians Education,	Guidelines	
and	feedback
Test	ordering	strategy	
was	developed	
systematically	and	it	
combined	feedback,	
education	on	guidelines	
and	quality	
improvement	sessions	
in	small	groups.	In	these	
groups	physicians	
discussed	eachothers	
test	ordering	behaviors,	
realted	to	guidelines	
and	made	
individual/group	plans	
for	change.13	groups	
engaged	in	th	entire	
strategy	whereas	14	
groups	received	
feedback	only.
Current	
Practice
6-months	pre	
intervention	
and	6	months	
post	
intervention
Mean	cost	reduction	
in	complete	
intervention	arm	
was	144	euro	larger	
per	physician	per	6-
months	compared	to	
the	physicians	in	the	
feedback	arm	
(p=0.048)
Winkens	et	al	 Netherlands Non-Randomized	Controlled	Trial 85	Primary	Care	Physicians Feedback Feedback	on	test	
ordering	behaviour	of	
general	practitioner	in	
biannual	reports	
between	1985-1995
Control	group	
consisted	of	
General	
Practitioners	in	
another	region	
of	the	
Netherlands	
that	did	not	
receive	
feedback	
(Laboratory	A)
5	years	(1985-
1990)
For	the	46	available	
tests,	the	
intervention	group	
ordered	101	983	
tests	in	1983	and	83	
062	in	1989.	The	
control	group	
ordered	182	283	in	
1983	and	276	401	in	
1989.	The	effect	of	
feedback	ellicited	a	
significant	decrease	
(p<	0.001)
Zaat	et	al Neatherlands Non-randomized	controlled	trial 75	Primary	Care	Physicians Education	&	Change	in	
Order	Form
Order	form	restriction.	
If	test	was	not	present	
on	the	form	physicians	
would	have	to	write	a	
hand	written	request	
(n=47	physicians)
Control	group	
used	the	
standard	form	
(n=28	
physicans)
12-months	post	
intervention
18%	reduction	in	the	
number	of	tests	
ordered	per	general	
practitioner,	per	
1,000	patients,	per	
month	during	the	
intervention	period.	
Following	the	re-
introduction	of	the	
standard	order	form	
the	ordering	
practices	returned	to	
their	old	patterns
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2.5 Serum Urea & Serum Creatinine 
 
 Serum urea and serum creatinine are nitrogenous end products of metabolism and are used 
as screening tests for renal function	35-39. Due to their distinct physiological properties their 
production and serum levels have distinct differences and implications	35. Creatine is formed in the 
liver, where it enters circulation and is predominantly absorbed and stored in muscle tissue	38. The 
majority of this stored creatine is phosphorylated into creatine phosphate in a reaction that is 
catalyzed by the enzyme creatine phosphokinase (CPK); a small portion of these stores are 
transformed into creatinine through a non-enzymatic reaction	38. Due to this relationship, 
creatinine production is closely related to lean muscle mass, it is relatively constant and minimally 
impacted by physical activity, protein intake and protein catabolism	35,38,39. Upon release, 
creatinine gains access to the plasma and it is exclusively excreted from the body by the kidney	35.  
Owing to the fact that creatinine is largely dependent on filtration at the glomerulus for excretion, 
the Glomerular Filtration Rate (GFR) is inversely related to the serum creatinine level. Therefore, 
serum creatinine level can be used to estimate GFR and thereby kidney function. Similarly, serum 
urea is the principal end product of protein and amino acid catabolism. It is produced when toxic 
ammonia from protein catabolism is converted to non-toxic urea through a process known as the 
Urea cycle	37.  Divergent to serum creatinine, serum urea is a poor indicator of glomerular 
filtration rate (GFR) as its’ production levels depends on several non-renal factors. In addition, 
urea is variably reabsorbed by the renal tubule after filtration, a process that is influenced by 
factors such as dehydration. Factors that can cause an increase in urea include: dehydration, 
congestive heart failure, shock, bleeding in the gastrointestinal tract, ingestion of large quantities 
of protein (diet) and illnesses that cause protein catabolism	35,37-39. When compared to serum urea, 
serum creatinine is a more specific test of renal function and is no less sensitive	37. Serum 
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creatinine is the preferred test to monitor kidney function and the progression of chronic kidney 
disease (CKD)	40. Assessing the clinical value of tests requires the consideration of test validity, 
convenience and expense. As tests of renal function, serum urea and serum creatinine are 
considered to be: low cost, requiring minimal resources, low risk and convenient	35. Although 
accompanied with limitations, serum urea may be useful in the diagnosis of acute kidney injury 
and in combination with serum creatinine may be useful in identifying: Azotemia, liver disease, 
nutritional requirements, and rhabdomyolysis	38,39. The use of these tests will be discussed further 
as it comprises a main feature of this paper. 
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2.6 Hemoglobin and Iron Tests 
 
 Anemia is characterized by a decrease in the total amount of haemoglobin (HgB) or the 
number of red blood cells (RBC) throughout the body	41,42. A reduction in this constituent of blood 
will result in the decreased ability of the circulatory system to transport adequate oxygen to the 
tissues	43. HgB is the iron-containing protein in red blood cells that binds oxygen and carries it 
throughout the body	43. A low HgB blood test result may indicate anemia	43,44. Emphasized causes 
of anemia include: sickle cell disease, thalassemias, iron deficient anemia (IDA), malaria, 
schistosomiasis and hookworm	42. Iron deficient anemia is one of the most critical and serious 
nutritional deficiencies globally to date	42,45. IDA is characterized by hypochromic and microcytic 
red blood cells in addition to low iron stores	41,44,46,47. Causes of IDA may include: Increased iron 
loss, increased iron demand, insufficient iron intake and inadequate iron absorption	43. Pre-
Menopausal women represent a large population of individuals who fulfill the criteria of IDA, 
reasons include: pregnancy, menstruation, breast feeding	44. Complete blood count (CBC) is useful 
for determining the mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH)	
46. MCV is the measure of the average RBC volume	46. MCH is a measure of concentration of 
haemoglobin in a given volume of RBC’s	46. A serum ferritin test should be performed in 
individuals with anemia; it reflects stored iron and is the most accurate test for diagnosing IDA	
44,46,47. It is important to note that ferritin levels may be deceptive while accompanied by acute or 
chronic inflammation	48. Similarly, Iron saturation is another indicator of iron stores in the body. 
This test takes into consideration two indices: (1) Serum Iron, (2) Total Iron binding capacity	49.  
The utilization of these tests forms the centerpiece of this paper and will be discussed further in the 
proceeding chapter 
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Summary of Literature Review 
 
 
 Healthcare spending has increased over the last several decades for a variety of reasons	1-3. 
In addition, frequency of laboratory test utilization has increased over time. The literature suggests 
that often utilization is inappropriate	5. Inappropriate utilization is accompanied by increased 
financial costs and decreased quality of care	6.  Systematic investigations have been undertaken to 
investigate the effect of interventions to reduce the unnecessary utilization of laboratory resources	
7,9. Authors found that multifaceted, educational interventions had the greatest degree of success; 
however, their sustainability it questioned	7,9. Interventions undertaken in primary care settings 
have had varied success	15-34. The high level of heterogeneity throughout the literature jeopardizes 
the generalizability and validity of the results. Similarly, the majority of the literature uses weak 
uncontrolled pre-post designs, short follow up periods and small sample sizes, decreasing the 
quality and validity of the investigations.  Several initiatives have recently been launched, 
internationally	11, nationally	12 and provincially	8,13,14, with the objective of reducing the 
unnecessary utilization of health care resources and improving care. Through these initiatives 
problem areas have been identified in Newfoundland Eastern Health Care Region particularly in 
primary care settings. Areas of interest identified include: serum urea, serum Creatinine, HgB and 
iron testing. 
 
   
 
 
 31 
Chapter 3: METHODS 
 
3.1 Ethical Considerations 
 A	complete	ethics	application	was	prepared	and	submitted	(reference	number:	2016.183)	to	the	Health	Research	Ethics	Board	(HREB)	for	the	secondary	use	of	data	approval	(Appendix	A).	Following	approval,	data	was	de-identified	and	encrypted	to	ensure	anonymity	of	all	identifying	information.	All	research	conducted	complied	with	the	Tri-Council	Policy	Statement:	Ethical	Conduct	for	Research	Involving	Humans	50.	All	members	of	the	research	team	were	required	to	sign	an	oath	of	confidentiality	through	the	Centre	of	Health	Informatics	and	Analytics	(CHIA).	Presently,	the	study	has	been	closed	with	HREB	due	to	the	fact	that	once	data	collection	is	completed	the	study	does	not	have	to	remain	open	(Appendix	A).	The	intent	of	these	data	is	for	internal	use	for	assessment,	management	and	improvement	purposes,	therefore,	this	investigation	is	classified	as	program	evaluation/quality	improvement	based	on	article	2.5	of	TCPS	guidelines	51.	For	these	reasons,	no	informed	consent	is	required.	An	Institutional	Review	Board	(IRB)	is	allowed	to	waive	the	requirements	for	obtaining	informed	consent	of	the	subjects	when:	(1)	The	risks	to	the	subjects	are	minimal;	(2)	Conducting	the	research	with	the	use	of	informed	consent	is	not	practicable	51		
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3.2 Participant Protection and Data Storage 
 	 As	previously	mentioned,	all	personal	identifiers	were	removed	from	the	data	to	ensure	the	privacy	and	confidentiality	of	those	included	in	the	data	set.	Only	individuals	with	the	required	ethical	approval	and	permission	are	able	to	view	the	identifiable	data.		 A	data	custodian	will	retain	all	collected	data	for	5	years	following	submission	date	of	this	paper.	The	data	will	remain	restricted	and	de-identified.	The	data	set	is	electronic;	therefore,	it	will	be	kept	on	an	encrypted	computer	and/or	encrypted	flash	drive	with	the	necessary	security	requirements	in	place.																
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3.3 Participants and Research Settings 
 
This investigation takes place in the Eastern Health region of Newfoundland and Labrador. 
Eastern Health is the largest health organization in Newfoundland and Labrador. This organization 
provides many health services to a regional population of greater than 300, 000. Eastern Health 
extends from St. John’s to Port Blandford and includes all of the communities on the Avalon, 
Burin and Bonavista peninsulas. The regional range of Eastern Health is included within a total of 
21,000 km2		52	(See	Figure	2).	The	participants	in	this	investigation	include	all	patients	in	the	Eastern	Health	Region	who	received	tests	for	Blood	Urea	Nitrogen,	serum	creatinine,	hemoglobin,	ferritin	and	iron	saturation	and	the	physicians	who	requested	these	laboratory	examinations.					
 
Figure 2 
Figure 2: The Geographic Boundaries of Eastern Health 
 Image of the Eastern Health Region with site locations depicted. Retrieved from: http://www.easternhealth.ca/AboutEH.aspx?d=1&id=1995&p=73 
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3.4 Data Sources 
 
Data concerning test-ordering behaviour was obtained from Eastern Health’s Meditech 
system through the Center for Health Informatics and Analytics (CHIA). Variables provided 
through this system includes: specimen ID, patient identifying code (encrypted), patients age, 
patients sex, patient status (inpatient V.s. outpatient) test being ordered, laboratory location used, 
submitting physician code, attending physician code, submitting physician specialty, attending 
physician specialty, test collection date, time, test result. Data for the blood urea nitrogen and 
serum creatinine was obtained for a 6-month period in 2014 (July 1st-December 31st). Data for the 
haemoglobin, ferritin and iron saturation tests were obtained for a 12 –month period (April 1st, 
2013 – April 1st,	2014). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 35 
3.5 Laboratory Test Reference Ranges 
 
  
All reference ranges were obtained from the Chief of Clinical Biochemistry with Eastern 
Health	53. The April 2016 version of adult reference ranges was used for this paper. The following 
ranges represent the normal values for each test. 
 
Serum Urea:       3.0 – 7.0 mmol/L (Male/Female) 
 
Serum Creatinine:   37 – 91 µmol/L (Female) 
                                     54 – 113 µmol/L (Male) 
 
Hemoglobin:    120 – 160 g/L (Female) 
    140 – 180 g/L (Male) 
 
MCV:    80 – 99 fL (Male/Female) 
MCH:    27 – 32 pg (Male/Female) 
 
Ferritin:    30 – 160 µg/L	(Female	18-49	years	of	age)	
30 – 300 µg/L (Male) 
30 – 300 µg/L (Female 50+ years of age) 
 
Iron Saturation:   0.2 – 0.55 (Male/Female) 
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3.6 Data Analysis 
 
All data were obtained in the form of Microsoft Excel files. Initially, files were organized 
into individual sheets for each test and preliminary data cleaning and analysis occurred at this 
stage. The initial stage of this analysis was comprised of interpreting the data set, cleaning and 
recoding variables in order to investigate the topic of interest and perform an efficient analysis. 
Initial data cleaning consisted of the removal of patients less than 18 years of age. Submitting 
physician specialty was recoded in order to create two separate variables: (1) submitting physician 
code (numerical), (2) submitting physician specialty (string). The patient type variable was 
recoded so that every patient type that ended in “IN” or “INx” was classified as inpatient; the 
remainders were coded as outpatients. Patients with missing values that were required for analysis 
(e.g. test result) were removed from the data set; the impact is believed to be negligible, however, 
this is discussed in sections allocated to limitations.  The analysis for this project only used 
descriptive statistics; no statistical parameters are provided. Following initial assessment, the 
analysis was moderately divergent for the two separate bundles of tests: (1) serum urea and serum 
creatinine, (2) hemoglobin, ferritin, iron saturation. The differing processes are as follows: 
 
3.6.1 Serum urea & Serum Creatinine 
 
The data set was initially analyzed using descriptive statistics of variables of interest. Test 
results for both tests were coded as normal or above normal. All tests that elicited a result that was 
less than the reference range were included in the normal category; for the purposes of this project 
our only interest was those tests results that were high and their associated clinical implications. 
All individuals who were less than eighteen years of age were removed from the data set; for the 
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purposes of this project we were only interested in adults. Serum creatinine and serum urea 
datasets were then linked using IBM SPSS Modeler 54. The data was linked by specimen I.D, age, 
sex, patient I.D, collection date and time, creating an inner join merge of the datasets. This allowed 
for the investigation of tests that were ordered in combination at the same time. Following data 
linkage, the data was stratified by specialties with the highest utilization and by test result. All data 
is presented using graphs, generated by the Microsoft excel program 55. 
3.6.2 Hemoglobin, Ferritin, Iron Saturation 
 
Similarly, the initial analysis consisted of investigating the data set by using descriptive 
statistics on variables of interest. In contrast to the previous test bundle, all test results that elicited 
a result that was higher than the reference range were included in the normal category; for this 
project we are only interested in results that were normal or low and their associated clinical 
implications. Once again, this data set contained only adults (all individuals less than 18 years of 
age removed). The process undertaken to link the data sets was slightly different for the potential 
over-utilization and under-utilization analysis. The number of tests ordered for the over-utilization 
analysis was obtained by merging the iron status tests data sets to the Hgb dataset, creating a semi 
outer join or left join. The iron status tests were linked to the patients’ first Hgb test using the 
unique patient code and collection date. The number of patients for the under-utilization analysis 
was obtained by first filtering the Hgb data set for unique patients only. This process allowed for 
the removal of repeating patient codes, allowing for an accurate representation of the number of 
patients who underwent testing.  Patients were then linked with their unique patient code to their 
first Hgb test using the collection date variable. The Hgb data set was then linked to the iron status 
data set using the unique patient code variable, creating a semi-outer join of the datasets. The data 
merges were achieved using IBM SPSS Modeler 54. Age was not used in the link due to the fact 
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that this bundle of tests contains the test ordering behaviours during a 12-month period; therefore, 
there is a possibility that someone’s age changed during this time period. The data was spot 
checked by comparing unique patient I.Ds between the original and linked data files to ensure the 
number of iron tests performed for each patient was accurate. The data was then categorized and 
analyzed by test result, number of iron tests performed in a specified date range, sex, specialty type 
and patient type. All data are presented using graphs, generated by Microsoft excel 55.  
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Chapter 4: RESULTS 
 
4.1 Serum Urea & Serum Creatinine 
 
 
4.1.1 Volume of Tests 
 
 227, 092 serum creatinine and 218, 289 serum urea tests were ordered during the time 
period of July 1st, 2014 – December 31st, 2014.  Of these laboratory investigations, 24.3% of 
serum creatinine tests and 33.1% of serum urea tests elicited elevated results (Figure 3). 
 68.1% of all serum creatinine tests and 66.9% of all serum urea tests were ordered for 
outpatients (Figure 4). 
 Figure 5 describes the number of serum urea and serum creatinine ordered each month. The 
pattern of test ordering remained relatively stable throughout the 6-month period with slight 
increases during the months of September and October. Serum creatinine was ordered at a slightly 
higher volume each month. 
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Figure 3. Total Number of Tests Performed in Eastern Health in 2014. A high volume of 
serum creatinine and serum urea tests were ordered in the regional health authority within the 6-
month period. A large proportion of both laboratory investigations elicited a normal test result. 
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Figure 4. Number of Tests Performed by Patient Type in Eastern Health in 2014. The 
majority of serum creatinine (68.1%) and serum urea (66.9%) laboratory tests were ordered for 
outpatients within the Eastern Health Region. 
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Figure 5. Number of Tests Performed by Month in Eastern Health in 2014.  Ordering of renal 
function tests in Eastern Health was relatively consistent during the 6-month period in 2014 with 
urea tests ordered at a slightly smaller volume each month. 
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4.1.2 Volume of Tests Ordered by General Practitioners 
 
 
 Figure 6 demonstrates the number of serum urea and serum creatinine tests ordered by 
practicing specialties within the Eastern Health Region. General Practitioners had the highest rates 
with 53.1% of serum creatinine and 52.5% of serum urea tests being ordered by this discipline. 
Internal Medicine had the subsequent highest ordering rates with 22.5% and 23.1% for creatinine 
and urea, respectively. A large proportion of serum urea (89.6%) and serum creatinine (90.1%) 
tests ordered by general practitioners were done so for outpatients (Figure 7 & Figure 8). 
Of the laboratory investigations requested by general practitioners, 24.3% of serum 
creatinine tests and 33.6% of serum urea tests elicited elevated results (Figure 9). 34, 411 (33.5%) 
of serum urea investigations ordered by a general practitioner for outpatients resulted in an 
elevated test outcome (Figure 10). 
 There is a high variability for the number of serum urea tests being ordered between 
general practitioners, with the top physician ordering 1,622 tests in a 6-month period (Figure 12 & 
Figure 13). 
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Figure 6. Number of Tests Performed by Specialty in Eastern Health in 2014. General 
Practitioners ordered the highest volume of serum creatinine (53.1% of total) and serum urea 
(52.5% of total) tests during the 6-month period in Eastern Health. The internal medicine specialty 
had the subsequent highest ordering rates for both tests. 
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Figure 7. Number of Urea Tests Ordered by Specialty and Patient Type in Eastern Health in 
2014. The highest volume of serum urea tests ordered for outpatients were requested by general 
practitioners. The highest number of urea tests ordered for inpatients were requested by the 
internal medicine specialty. 
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Figure 8. Number of Serum Creatinine Tests Ordered by Specialty and Patient Type in 
Eastern Health in 2014. The highest volume of serum creatinine tests ordered for outpatients 
were requested by general practitioners. The highest number of serum creatinine tests ordered for 
inpatients were requested by the internal medicine specialty. 
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Figure 9. Total Number of Tests Ordered by General Practitioners in Eastern Health in 
2014. A large proportion of serum creatinine (75.7%) and serum urea (66.4%) tests ordered within 
the 6-month period by general practitioners elicited a normal result. 
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Figure 10. Result of Serum Urea Tests Ordered for Outpatients by Physician Type in 
Eastern Health in 2014. The majority of urea tests performed for outpatients were requested by 
general practitioners and elicited a normal result. 
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Figure 11. Result of Serum Creatinine Tests Ordered for Outpatients by Physician Type in 
Eastern Health in 2014. The majority of serum creatinine tests performed for outpatients were 
requested by general practitioners and elicited a normal result. 
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Figure 12. Serum Urea Tests Ordered by General Practitioners in Eastern Health in 2014. 
There is a great deal of variability in the test ordering behaviors of general practitioners for the 
serum urea laboratory investigation. A small proportion of the general practitioners within the 
Eastern Health Region may be responsible for a large proportion of ordered tests. 
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Figure 13. Top 20 General Practitioners by Volume of Serum Urea Performed for 
Outpatients in the Eastern Health Region during a 6-month period in 2014. There is a great 
deal of variability in the test ordering behaviors of general practitioners for the serum urea 
laboratory investigation. A small proportion of the general practitioners within the Eastern Health 
Region may be responsible for a large proportion of ordered tests. 
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4.1.3 Serum Urea & Serum Creatinine Coupled 
 
 Table 2 compares the number of serum urea and serum creatinine tests ordered in the same 
draw based on the ordering physicians specialty for outpatients. 141, 112 serum urea (96.7% of 
total for outpatients) and serum creatinine (91.3% of total for outpatients) were ordered together. 
General practitioners ordered the highest quantity of tests in combination for outpatients (70.9%) 
with Internal Medicine following, accounting for 14.5% of all coupled tests. These findings 
highlight the key point that these tests are almost always ordered together, rendering the urea test 
redundant. These two tests are likely being ordered for the same purpose, therefore the redundancy 
is that serum creatinine is the more specific test to assess renal function and monitor the progress 
of chronic kidney disease. 
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Table 2: Number of Serum Urea and Serum Creatinine Tests Ordered Together by Specialty in 
Eastern Health for Outpatients (July 1, 2014 – December 31, 2014) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Submitting	Physician	Specialty/Laboratory	Test	Count
n	(%)
General	Practice 100,	028	(70.9)
Internal	Medecine 20,	447		(14.5)
Other 10,	704	(7.6)
Unknown 9,	933	(7.0)
Total 141,	112
Number	of	Serum	Creatine	and	Serum	Urea	
Ordered	in	Same	Draw
Combined	Total	
N
200,	056
40,	894
21,	408
19,	866
282,	224
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4.1.4 Test Results of Coupled Serum Urea & Serum Creatinine 
 
 Figure 14 demonstrates the independent test results for serum urea and serum creatinine 
laboratory investigations ordered together by general practitioners for outpatients only. 
The largest volume of tests, 69, 274 (69.3%), elicited both normal serum urea and serum creatinine 
results. 13, 566 (13.6%) were found to have an elevated urea and a normal creatinine result. Tests 
that elicited elevated levels of both serum urea and serum creatinine totaled 11, 957 (12.0%). 
Normal serum urea and elevated serum creatinine test results accounted for 5, 231 (5.2%), the 
smallest volume of all test result categories. 
Figure 15 portrays the distribution of serum urea results that were ordered by general 
practitioners in combination with a normal serum creatinine result for outpatients only. 13, 566 
(16.4%) of serum urea tests ordered with a normal serum creatinine produced an elevated result. 
7,649 (56.4%) of these abnormal serum urea tests have a result between 7.1 – 8.0 mmol/L. 11,095 
(81.8%) between 7.1 – 9.0 mmol/L. 12, 540 (92.4%) between 7.1 – 10.0 mmol/L.  
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Figure 14. Serum Creatinine and Serum Urea Laboratory Investigations Ordered at the 
Same Time be General Practitioners during a 6-month period in the Eastern Health Region. 
This figure shows the volume of tests ordered in combination and their corresponding results. A 
considerable proportion of the coupled serum creatinine and serum urea tests (69.3%) had a 
normal outcome for both tests. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
62,274	(69.3%)	
11,957	(12.0%)	 13,566	(13.6%)	
5,231	(5.2%)	
0	
10,000	
20,000	
30,000	
40,000	
50,000	
60,000	
70,000	
Both	Normal	 Both	Elevated	 Urea	Elevated	&	Creatinine	
Normal	
Normal	Urea	&	Elevated	
Creatinine	
N
um
be
r	o
f	T
es
ts
	
Combined	Laboratory	Test	Results	
Coupled	Serum	Creatinine	&	Serum	Urea	for	Outpatients	as	Ordered	
by	General	Practitioners	in	Eastern	Health	(July	1,	2014	-	December	
31,	2014)	
 56 
 
 
Figure 15. The distribution of Serum Urea tests results in outpatients with a normal serum 
creatinine test outcome as ordered by a general practitioner. The urea laboratory investigation 
is considered to be abnormal when the outcome is greater than 7.0 mmol/L. A large proportion of 
the abnormal urea tests results in outpatients with a normal serum creatinine are only elevated 
within 3.0 mmol/L (92.4%). This abnormal result caused by a small elevation may not provide any 
clinical value. 
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4.2 Hemoglobin (Hgb), Ferritin & Iron Saturation 
 
 4.2.1 Volume of Testing 
 
 During the time period of April 1st,	2013 – April 1st, 2014, the Hemoglobin laboratory test 
was ordered more frequently in comparison to Ferritin and Iron saturation tests. During this 12-
month period Hemoglobin was ordered 450, 792 times, Ferritin was performed 86, 293 times and 
iron saturation laboratory investigations were performed 23, 415 times (Figure 16). 
 Hemoglobin, ferritin and iron saturation were performed in larger quantities for females as 
compared to males within the Eastern Health Region: 55.5%, 63.4% and 56.0%, respectively 
(Figure 17). 
 320, 121 (71.1%) of all Hgb tests were ordered for outpatients. The Majority of ferritin and 
iron saturation tests were also ordered for outpatients, 84, 670 (98.1%) and 22, 212 (94.9%), 
respectively (Figure 18). 
 Individual Test ordering behavior was relatively consistent throughout the 12-month 
period, with Hgb being ordered in a substantially greater volume per month (Figure 19).  
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Figure 16. Total Number of Ferritin, Hemoglobin and Iron Saturation Tests Performed in 
Eastern Health within a 12-month. A high volume of iron status and hemoglobin tests were 
ordered during the 12-month period. Of particular interest is the number of hemoglobin tests that 
were requested (n= 450, 792). This is a large volume of tests when taking into consideration that 
the Eastern Health Regional Authority has approximately 300,000 patients. 
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Figure 17. Total Number of Ferritin. Hemoglobin and Iron Saturation Tests Performed by 
Gender in Eastern Health within a 12-month period. The iron status and hemoglobin laboratory 
investigations were ordered more often for female patients. 
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Figure 18. Number of Tests Performed by Patient Type in Eastern Health within a 12-month 
period. The majority of hemoglobin (71.1%), ferritin (98.1%) and iron saturation (94.9%) tests 
were ordered for outpatients compared to inpatients. 
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Figure 19. Number of Tests Performed by Month in Eastern Health during a 12-month 
period. Test ordering behaviours were relatively consistent each month for the three tests with 
hemoglobin tests being ordered at a substantially greater volume. 
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4.2.2 Volume of Testing by General Practitioners 
 
  During the 12- month period, general practitioners ordered all three tests in a higher 
volume for outpatients compared to other specialties within the Eastern Health Region. Ferritin 
laboratory investigations had the highest proportion of tests ordered by general practitioners 
(82.5%). General practitioners ordered 65.8% and 53.5% of all Hgb and iron saturation tests, 
respectively. Internal medicine practitioners were the following specialty for the highest ordering 
rates with considerably less tests requested for Hgb, ferritin and iron saturation as compared to 
general practitioners: 13.5%, 7.3% and 19.3%, respectively (Figure 20). 
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Figure 20. Number of Tests Performed for Outpatients by Specialty in Eastern Health 
during a 12-month period. General practitioners had the highest ordering rates for ferritin (82.5% 
of total), hemoglobin (65.8% of total) and iron saturation (53.5% of total) tests. 
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4.2.3.1 Overutilization Overview 
 
For the purposes of this analysis, patients were considered to be non-anemic if their 
hemoglobin laboratory test result was within the normal range for their gender (male = 140 – 180 
g/L; female = 120 – 160 g/L).  A test result below 110 g/L for both males and females was 
considered to be anemic. This cut off was chosen as it falls below the normal range of both 
genders and likely reflective of a true anemia.  
Figure 21 describes the number of iron tests ordered in the Eastern Health region for 
outpatients during the 12-month period by the patient’s result of their first hemoglobin test. 8,976 
iron tests were ordered in patients with an anemic (<110 g/L) result for their first Hgb test. 16, 933 
and 73, 445 iron tests were ordered for patients with a low Hgb and non-anemic result, 
respectively. 89.0% of the iron tests ordered for non-anemic (first Hgb) outpatients elicited a 
normal iron status result.   
 34.2% of all ferritin tests and 62.8% of all iron saturation tests ordered for outpatients were 
requested in the same draw as an Hgb test during the 12-month period in Eastern Health (Figure 
22). 
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Figure 21. Number of Iron Tests Ordered for outpatients by Anemia Result of the Patients 
First Hemoglobin test in Eastern Health during a 12-month Period. A large proportion of iron 
status tests were ordered for patients with a non-anemic first Hgb test result (n=73, 445). The 
majority of these investigations resulted in a normal outcome (89.0%). 
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Figure 22. Iron Tests Ordered for Outpatients in the Eastern Health Region during a 12-
month period. 34.2 % of all ferritin and 62.8% of all iron saturation laboratory investigations 
ordered for outpatients were requested in the same draw as a hemoglobin test.  
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4.2.3.2 Overutilization by General Practitioners 
 
Figure 23 describes the number of iron tests ordered for outpatients by general practitioners 
based on the patient’s anemia status derived from their first Hgb test between the time period of 
April 1st, 2013-April 1st, 2014. 62, 053 iron tests were requested by general practitioners for 
outpatients with a non-anemic (normal) first Hgb test result within the 12-month period. 89.6% of 
those iron status tests produced a normal result.   
 29.9% of all ferritin tests and 70.2% of all iron saturation tests ordered by general 
practitioners for outpatients were requested at the same time as an Hgb test (Figure 24). 
 General practitioners requested 66, 904 iron tests within 90 days (+/-) of an outpatient’s 
first Hgb test within the 12-month period. 54, 905 of the iron tests were requested for patients with 
a non-anemic (normal) result for their first Hgb test; 90.1% of them eliciting a normal iron status 
result (Figure 25). 
General practitioners requested 10,786 iron tests more than 90 days (+/-) of an outpatient’s 
first Hgb test. 7,147 tests were ordered for patients whose first Hgb test produced a non-anemic 
result. 6, 126 (85.3%) of iron tests ordered for this patient population elicited a normal iron status 
result (Figure 26). 
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Figure 23. Number of Iron Tests Ordered by General Practitioners for Outpatients by the 
Result of the Patients First Hemoglobin Test Requested During the 12-month Period in the 
Eastern Health Region.  A large volume of iron status tests were ordered by general practitioners 
for outpatients whose first hemoglobin test elicited a non-anemic (normal) result (n=62,053).  
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Figure 24. Iron Tests Ordered for Outpatients in Eastern Health by General Practitioners. 
This figure describes the iron tests that were ordered for outpatients by general practitioners in the 
same draw as a hemoglobin test or independently during the 12-month period in the Eastern 
Health Region. 70.2% of iron saturation tests ordered by general practitioners for outpatients were 
ordered in the same draw as a hemoglobin test. 29.9% of ferritin tests ordered by a general 
practitioner for outpatients were ordered in the same draw as a hemoglobin test. 
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Figure 25. Iron Tests Ordered for Outpatients by General Practitioners within 90 days of the 
Patients First Hemoglobin test during the 12-month period in the Eastern Health Region. 54, 
905 iron status tests were ordered within 90 days of a first hemoglobin test that produced a normal 
(non-anemic) outcome. 90.1% of these iron status investigations elicited a normal result. 
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Figure 26. Iron Tests Ordered for Outpatients by General Practitioners Greater than 90 
days of the Patients First Hemoglobin test during the 12-month period in the Eastern Health 
Region. 7, 147 iron status tests were ordered greater than 90 days of a first hemoglobin test that 
produced a normal (non-anemic) outcome. 85.3% of these iron status investigations elicited a 
normal result. 
 
 
 
 Table 3 describes the number of iron tests ordered within 90 days (+/-) of outpatients (≤ 50 
years of age) first Hgb test, stratified by gender.  
Table 4 describes the number of iron status tests requested within 90 days (+/-) of 
outpatients (> 50 years of age) first Hgb test, stratified by gender. 
General practitioners requested 27, 689 iron status tests in outpatients (≤ 50 years of age) 
within 90 days (+/-) of their first Hgb test within the 12-month period in Eastern Health. 17, 854 
iron tests were ordered for females aged 50 years or younger who had an associated non-anemic 
(normal) first Hgb test result. 84.4% of those iron investigations elicited a normal result. 6, 796 
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iron investigations were requested for males aged 50 years or younger whose first Hgb test 
resulted in a non-anemic outcome. 97.1% of those ordered iron laboratory investigation produced a 
normal result (Table 5). 
General practitioners requested 39, 215 iron tests in outpatients (> 50 years of age) within 
90 days (+/-) of their first Hgb Test during the April 1st, 2013-April 1st, 2014 time period. 19, 337 
iron investigations were requested for females who had an associated non-anemic first Hgb test 
result and were older than 50 years of age. 90.4% of those iron status tests elicited a normal result. 
10, 913 iron tests were ordered in men with a normal first Hgb test result and were older than 50 
years of age. 94.6% of those iron investigations produced a normal result (Table 6). 
79.6% of iron tests were ordered by general practitioners, for outpatients with a non-
anemic (first Hgb) test result within the 12-month period. 54, 905 of these investigations were 
requested within +/- 90 days of the patients first Hgb and 90.1% of the tests elicited a normal iron 
status result. 95.9% (n=52,699) of these patients were never anemic within the 12-month period 
(none of the patients’ subsequent tests were anemic). These findings indicate that a large 
proportion of iron status tests are being ordered for patients who do not have an Hgb test 
indicating that they are anemic. The vast majority of the iron status tests elicited a normal result, 
further supporting that these tests may be being used in an inappropriate clinical scenario, 
supporting potential overutilization by general practitioners. 
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Table 3: Number of Iron Tests Ordered for Outpatients ≤ 50 years of age within 90 days (+/-) of their First 
Hgb Test Stratified by Gender (Eastern Health: April 1, 2013 - April 1, 2014) 
              
  Iron Test Result   
  Normal Low Unknown  Total  
First Hgb Result Gender n (%total) n (%total) n(%total)   N 
       
Non-Anemic       
 Female 17,324 (83.9%) 3,321 (16.0%) 11 (0.1%)  20,656 
 Male 7,742 (96.8%) 260 (3.2%) 0  8,002 
       
Low       
 Female 871 (47.7%) 950 (51.9%) 7 (0.4%)  1,829 
 Male 911 (80.7%) 217 (19.2%) 1 (0.1%)  1,129 
       
Anemic       
 Female 299 (27.0%) 771 (69.6%) 38 (3.4%)  1,108 
  Male 139 (61.2%) 85 (37.4%) 3 (1.4%)   227 
 
Table 4: Number of Iron Tests Ordered for Outpatients > 50 years of age within 90 days (+/-) of their First Hgb 
Test Stratified by Gender (Eastern Health: April 1, 2013 - April 1, 2014) 
              
  Iron Test Result   
  Normal Low Unknown  Total  
First Hgb Result Gender n (%total) n (%total) n(%total)   N 
       
Non-Anemic       
 Female 20,031 (89.7%) 2,294 (10.2%) 10 (0.1%)  22,335 
 Male 12,068 (94.2%) 729 (5.7%) 8 (0.1%)  12,805 
       
Low       
 Female 1,960 (68.4%) 898 (31.4%) 6 (0.2%)  2,864 
 Male 5,147 (81.2%) 1,187 (18.7%) 1 (0.1%)  6,335 
       
Anemic       
 Female 1,455 (56.8%) 1098 (42.8%) 11 (0.4%)  2,564 
  Male 975 (65.7%) 506 (34.1%) 3 (0.2%)   1,484 
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Table 5: Number of Iron Tests Ordered by General Practitioners for Outpatients ≤ 50 years of age within 
90 days (+/-) of their First Hgb Test Stratified by Gender (Eastern Health: April 1, 2013 - April 1, 2014) 
              
  Iron Test Result   
  Normal Low Unknown  Total  
First Hgb Result Gender n (%total) n (%total) n(%total)   N 
       
Non-Anemic       
 Female 15,067 (84.4%) 2,781 (15.6%) 6 (0.03%)  17, 854 
 Male 6,602 (97.1%) 194 (2.9%) 0  6,796 
       
Low       
 Female 673 (47.0%) 752 (52.6%) 6 (0.4%)  1,431 
 Male 633 (82.9%) 130 (17.0%) 1 (0.1%)  764 
       
Anemic       
 Female 168 (21.4%) 587 (74.8%) 30 (3.8%)  785 
  Male 23 (39.0%) 35 (59.3%) 1 (1.7%)   59 
 
Table 6: Number of Iron Tests Ordered by General Practitioners for Outpatients > 50 years of age within 
90 days (+/-) of their First Hgb Test Stratified by Gender (Eastern Health: April 1, 2013 - April 1, 2014) 
              
  Iron Test Result   
  Normal Low Unknown  Total  
First Hgb Result Gender n (%total) n (%total) n(%total)   N 
       
Non-Anemic       
 Female 17,489 (90.4%) 1,840 (9.5%) 8 (0.1%)  19,337 
 Male 10,332 (94.6%) 574 (5.3%) 7 (0.1%)  10,913 
       
Low       
 Female 1,484 (68.1%) 689 (31.6%) 5 (0.3%)  2,178 
 Male 3,756 (82.0%) 824 (18.0%) 0  4,580 
       
Anemic       
 Female 878 (54.4%) 726 (45.0%) 9 (0.6%)  1,613 
  Male 338 (56.9%) 256 (43.1%) 0   594 
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4.2.3 Potential Test Overutilization 
 
Figure 27 provides a streamlined collection of the data presented in the previous figures 
which may support potential test overutilization. 
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Figure 27: Cascade of Potential Overutilization. This cascade highlights the points of interest 
that may support potential test overutilization of the iron status and hemoglobin tests in the Eastern 
Health Region during a 12-month period. 
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 4.2.4.1 Underutilization Overview 
 
Figure 28 describes the number of outpatients by the anemia status of their associated first 
Hgb test and if they underwent iron status laboratory investigations during the 12-month period in 
the Eastern Health Region.  
There are 206, 864 unique patients within the Hgb data set (Figure 28). 75.0% of all 
outpatients first Hgb test resulted in a normal outcome. 12.0% of outpatients had a low first test 
result. 3.9% elicited an Anemic (110 g/L) first Hgb test result. 3.0 % of all outpatients were 
anemic and underwent iron testing. 2,981 (1.6%) of outpatients with an anemic first Hgb test 
outcome did not have iron laboratory investigations undertaken (Figure 28). 
10.1% of all outpatients with an anemic result and a low MCH and/or MCV were not 
ordered iron test investigations during the 12-month period (Figure 29). 
32.6 % of anemic (first Hgb) females and 25.0% of anemic males (first Hgb) 50 years of 
age or younger with an associated low MCH and/or MCV did not have an iron test performed 
within 1-year of their first Hgb (Table 7). 
35.0% of anemic (first Hgb) females and 41.8% of anemic males (first Hgb) older than 50 
years of age with an associated low MCH and/or MCV did not have an iron test requested within 
the 12-month period (Table 8). 
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Figure 28. Number of Outpatients by Anemia Status of Patients First Hemoglobin Tests and 
their Associated Iron Status Tests in the Eastern Health Region during a 12-month period.  
2, 981 outpatients had an anemic first hemoglobin test result and did not undergo iron testing 
during the 12-month period. Representing a potential missed opportunity for testing. 
 
Figure 29. Iron Testing in Anemic (first Hgb) Outpatients by MCH/MCV result in the 
Eastern Health Region during a 12-month period. 629 anemic outpatients with an associated 
low MCH or MCV did not undergo iron testing during a 12- month period in Eastern Health  
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Table 7: Number of Anemic Outpatients (first Hgb) ≤ 50 years of age with Low MCV 
and/or MCH by Iron testing in Eastern Health (April 1, 2013 - April 1, 2014) 
          
 Total  Iron Testing 
Gender/Testing n Date Range Yes No 
Female 709    
  Within 1-month of First Hgb 403 (56.8%) 306 (43.2%) 
  Within 3-months of First Hgb 443 (62.5%) 266 (37.5%) 
  Within 1-year of First Hgb 478 (67.4%) 231 (32.6%) 
Male 64    
  Within 1-month of First Hgb 39 (60.9%) 25 (39.1%) 
  Within 3-months of First Hgb 44 (68.8%) 20 (31.3%) 
  Within 1-year of First Hgb 48 (75.0%) 16 (25.0%) 
          
 
 
 
Table 8: Number of Anemic Outpatients (first Hgb) > 50 years of age with Low MCV 
and/or MCH by Iron testing in Eastern Health (April 1, 2013 - April 1, 2014) 
          
 Total  Iron Testing 
Gender/Testing n Date Range Yes No 
Female 741    
  Within 1-month of First Hgb 377 (50.9%) 364 (49.1%) 
  Within 3-months of First Hgb 435 (58.7%) 306 (41.3%) 
  Within 1-year of First Hgb 482 (65.0%) 259 (35.0%) 
Male 294    
  Within 1-month of First Hgb 127 (43.2%) 167 (56.8%) 
  Within 3-months of First Hgb 157 (53.4%) 137 (46.6%) 
  Within 1-year of First Hgb 171 (58.2%) 123 (41.8%) 
          
 
259 anemic females less than fifty years of age did not undergo iron testing within 1-year 
of their first Hgb. Similarly, 259 females and 123 males over the age of fifty did not undergo iron 
status testing within 1-year of their first Hgb. These patients should have had iron status testing 
investigations in order to determine the cause of their anemia. These findings represent a missed 
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opportunity for testing and potential underutilization of these laboratory resources. 
 
4.2.4.2 Underutilization by General Practitioners 
 
Figure 30 describes the number of outpatients by the anemia status of their associated first 
Hgb test as requested by a general practitioner and if they underwent iron status laboratory 
investigations during the 12-month period in the Eastern Health Region. 
139, 223 unique outpatients had their first Hgb test requested by a general practitioner. 
84.7% of all unique outpatients first Hgb test requested by a general practitioner resulted in a 
normal outcome. 12.4% elicited a low and 2.9% an anemic (< 110 g/L) first Hgb test result within 
the 12- month period. 52.1% of outpatients with a normal first Hgb test result as requested by a 
general practitioner did not undergo iron-testing investigations. 1, 697 (1.3%) anemic outpatients 
(first Hgb) as ordered by a general practitioner did not have an iron test performed (Figure 30). 
34.8% of all anemic outpatients (first Hgb test) as requested by general practitioners with 
an associated normal MCH and MCV result did not have an iron test performed.  10.1% of all 
outpatients with an anemic Hgb and a low MCH and/or MCV test result as ordered by a general 
practitioner were not ordered further iron test investigations during the 12-month period (Figure 
31). 
 28.3 % of anemic (first Hgb) females and 13.9% of anemic males (first Hgb ordered by 
general practitioner) 50 years of age or younger with an associated low MCH and/or MCV did not 
have an iron test performed within 1-year of their first Hgb (Table 9). 
32.6% of anemic (first Hgb ordered by general practitioner) females and 39.5% of anemic 
males (first Hgb) older than 50 years of age with an associated low MCH and/or MCV did not 
have an iron test requested within the 12-month period (Table 10). 
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Figure 30. Number of Outpatients by Anemia Status of First Hgb Test as Ordered by a 
General Practitioner and Associated Iron Status test during a 12-month Period in Eastern 
Health. 1, 697 anemic patients (first hemoglobin ordered by a general practitioner) did not 
undergo iron testing within the 12-month period. Representing a potential missed opportunity of 
testing. 
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Figure 31. Iron Testing in Anemic Outpatients (first Hgb) as Ordered by a General 
Practitioner by MCH/MCV result in Eastern Health during a 12-month period. 381 anemic 
outpatients with an associated low MCH or MCV did not undergo iron testing within the 12-month 
period. Representing a potential missed opportunity for testing. 
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Table 9: Number of Anemic Outpatients (first Hgb) ≤ 50 years of age with Low MCV and/or 
MCH by Iron testing in Eastern Health (April 1, 2013 - April 1, 2014) as Ordered by General 
Practitioners 
          
 Total  Iron Testing 
Gender/Testing n Date Range Yes No 
Female 481    
  Within 1-month of First Hgb 307 (63.8%) 174 (36.2%) 
  Within 3-months of First Hgb 329 (68.4%) 152 (31.6%) 
  Within 1-year of First Hgb 345 (71.7%) 136 (28.3%) 
Male 36    
  Within 1-month of First Hgb 27 (75.0%) 9 (25.0%) 
  Within 3-months of First Hgb 30 (83.3%) 6 (16.7%) 
  Within 1-year of First Hgb 31 (86.1%) 5 (13.9%) 
          
 
 
 
Table 10: Number of Anemic Outpatients (first Hgb) > 50 years of age with Low MCV and/or 
MCH by Iron testing in Eastern Health (April 1, 2013 - April 1, 2014) as Ordered by General 
Practitioners 
          
 Total  Iron Testing 
Gender/Testing n Date Range Yes No 
Female 512    
  Within 1-month of First Hgb 278 (54.8%) 234 (45.2) 
  Within 3-months of First Hgb 320 (62.5%) 192 (37.5%) 
  Within 1-year of First Hgb 345 (67.4%) 167 (32.6%) 
Male 185    
  Within 1-month of First Hgb 90 (48.6%) 95 (51.4%) 
  Within 3-months of First Hgb 101 (55.0%) 84 (45.0%) 
  Within 1-year of First Hgb 112 (60.5%) 73 (39.5%) 
          
 
136 anemic females less than fifty years of age did not undergo iron testing within 1-year 
of their first Hgb. Similarly, 167 females and 73 males over the age of fifty did not undergo iron 
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status testing within 1-year of their first Hgb. These patients should have had iron status testing 
investigations in order to determine the cause of their anemic result. These findings may represent 
a missed opportunity for testing and potential underutilization of these laboratory resources. Under 
testing has the potential to result in a delay or missed diagnosis of illness, potentially creating 
further implications for the patient and healthcare system downstream. It is, however, important to 
take into consideration that the failure to follow up with iron testing in these anemic cases may 
have been due to other factors (e.g. patient mortality). 
 
 
In terms of our investigations of interest, missing an opportunity for testing in younger 
women may mean not treating an iron deficiency. In an older individual, it might represent a 
missed opportunity to investigate the cause of the anemia (diagnosing a bowel cancer for 
example). Ultimately, under testing in individuals where it may be indicated will decrease the 
quality of care provided for patient populations. It is important to take into consideration that the 
failure to follow up with iron testing in these anemic cases may have been due to other factors (e.g. 
patient mortality). 
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4.2.4 Potential Test Underutilization 
 
Figure 32 provides a streamlined collection of the data presented in the previous figures 
which may support potential test underutilization. 
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 Figure 32: Cascade of Potential Underutilization. This cascade highlights the points of interest 
that may support potential test underutilization of the iron status and hemoglobin tests in the 
Eastern Health Region during a 12-month period. 
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Chapter 5: DISCUSSION 
  
 We examined the utilization of renal function tests (serum urea & serum creatinine), iron 
status tests (ferritin, iron saturation) and hemoglobin. These tests were analyzed individually and 
in combination with the other tests included within their specified bundle. Variables of interest 
assessed include: submitting physician specialty, patient age, patient sex, laboratory test result and 
patient type (inpatient vs. outpatient).  Additionally, interventions undertaken to modify test-
ordering behaviours are discussed in order to recommend an approach to any issues identified in 
the laboratory test utilization analysis. 
 Following analysis of the renal function tests we concluded that serum urea is commonly 
coupled with serum creatinine and is ordered in large numbers by general practitioners. This is 
likely unnecessary as the majority of test results are normal and there is a high degree of 
concordance between the information gained from creatinine and urea levels. Additionally, there is 
a great deal of variability in serum urea laboratory test ordering amongst general practitioners. 
However, a portion of this variability may be explained by taking into consideration that general 
practitioners included within this data set are not seeing the same patient numbers or profile. 
 We concluded that there is a large number of iron status tests being performed, particularly 
in general practice. The minority of iron status tests performed were iron saturation investigations, 
which are likely, unnecessary when ferritin is available. Large numbers of these tests were 
performed in non-anemic patients, which may be only indicated in particular subsets of patients. 
Underutilization was found to be small in volume, however, may have considerable clinical 
implications in specific patient populations. 
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5.1 Serum Urea & Serum Creatinine  
 
227, 092 serum creatinine and 218, 289 serum urea (Figure 3) tests were ordered in the 
Eastern Health Region during the 6-month period. The number of tests ordered during this time 
period emphasizes the substantial utilization of both kidney function tests when taking into 
consideration that the Eastern Health Authority services a regional population of approximately 
300, 000 people54. Serum creatinine is the preferred test to monitor kidney function and the 
progression of chronic kidney disease (CKD); serum should not be used to evaluate kidney 
function in stable patients, as it is the less specific test37. However, the data indicates that the 
majority of serum urea tests (96.8% of total) are coupled with serum creatinine tests. 
 
General practitioners ordered the largest number of serum urea tests (52.5% of total; Figure 
6). Similarly, the greatest quantities of serum urea tests coupled with serum creatinine were 
requested by general practitioners (52.9%; Table 2). This may be expected as general practitioners 
are considered to be the front-line investigators of the health care system58, however, requesting 
serum urea in these large numbers and in combination with serum creatinine is likely unnecessary. 
Serum urea may be useful in the diagnosis of acute kidney injury and the assessment of its origin	
38,39 and therefore may be useful in specific clinical situations. As a physician, particularly from a 
community oriented general practitioner perspective, it is pertinent that the appropriate services are 
made available to each patient in order to identify health problems and monitor the impact of 
changes. The use of these tests in large numbers and in combination may be indicative of potential 
over-utilization in clinical screening investigations that are not indicated based on the clinical 
scenario. General practitioners play an extensive role in the monitoring of chronic conditions of 
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patients within the health care system; a population in which serum urea can be a non-specific 
indicator of pre-renal factors effecting its’ levels 37,39-41. A large proportion of coupled serum 
creatinine and serum urea tests elicited normal results for both tests (69.3%; Figure 14), supporting 
potential over-utilization while performing clinical investigations. Additionally, a noteworthy 
proportion (13.6%; Figure 14) of these tests produced an elevated serum urea result accompanied 
by a normal serum creatinine result. This combination of results while evaluating kidney function 
in stable patients has the potential to cause undesired diagnostic uncertainty. A possible response 
to uncertainty would be to order the test again, doubling up on unnecessary testing.  This is further 
supported by the data, which demonstrates that 92.4% of patients with laboratory investigations 
that elicited an increased serum urea and a normal serum creatinine are elevated only within 3 
mmol/L of the classified normal range (3 – 7 mmol/L) (Figure 15). This elevation in serum urea 
may be of minimal clinical significance.  
 
There is a great deal of variability in the number of serum urea tests ordered by general 
practitioners throughout the Eastern Health Region. Albeit a proportion of the variability may be 
explained by differences in geographical location (rural vs. urban) and discrepancies in population 
demographics throughout the region. Understanding the large variability may require a shift in 
focus from the patient population to the general practitioners themselves. The pattern of test 
ordering may be reflective of the physician’s year of graduation as medical school curriculum 
teachings are constantly being modified.  
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5.2 Iron Testing 
  Analysis of laboratory investigations over a 12-month period in the Eastern Health Region 
exhibits a high volume of iron testing. As expected, due to their primary care role in the health 
care system	56, general practitioners were found to have the highest ordering rate for these tests. 
Iron saturation tests were the minority of iron status investigations ordered, with 12, 094 requested 
by general practitioners. This measure of iron status is likely unnecessary when ferritin is available 
as a serum ferritin test reflects stored iron and is the most accurate test for diagnosing Iron 
Deficient Anemia (IDA)	44,46,47.  
 
There is a large of patients who underwent iron testing as ordered by general practitioners, 
despite not being anaemic (79.6% of total; Figure 23). Furthermore, a large proportion of these 
patients’ subsequent Hgb tests did not identify any anemia (95.8%; Figure 27). 38.3% (Figure 27) 
of these patients had an iron test ordered in the same draw as an Hgb. The high volume of iron 
status tests ordered in patients with a non-anemic result (normal Hgb, MCV, MCH) is likely 
unnecessary and provides support for potential test over-utilization. Iron testing is not clinically 
indicated in patients who present with normal hemoglobin, MCV and MCH and are not 
experiencing symptoms of iron deficiency	57.  
However, the literature suggests that iron testing may be beneficial in particular 
populations even when found to be non-anemic. Pre-menopausal women represent a large 
population of patients who may be at risk of IDA	44, therefore, iron testing may be acceptable in 
symptomatic young women of reproductive age due to the loss of iron during menstruation and the 
increased demand for iron during pregnancy	57. Ordering a serum ferritin in pre-menopausal, non-
anemic women is likely justified as it aids in identifying patients who may benefit from iron 
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therapy. The evidence shows that in non-anemic women of reproductive age with a low serum 
ferritin level, oral	58,59 and intravenous 60 iron supplementation produces improvements in fatigue 
58,60, maximal and submaximal 59 exercise performance. However, the data indicates that there is a 
large volume of iron status investigations performed in older (> 50 years old) males and females; 
particularly patients whose first Hgb test result produced a normal result, further supporting 
potential test overutilization. 
 
Underutilization of iron testing is small in volume; however, it is important to take into 
consideration as it may have clinical importance and impact outcomes in specific patient 
populations. 44.9% (Table 9) of females who were less than 50 years of age did not undergo iron 
testing within 1-year of their first anemic Hgb test result (Hgb <110 g/L, low MCH and/or MCV). 
This underutilization of the indicated clinical test produces a potential missed opportunity to 
mitigate factors that may affect pregnancy and treat IDA associated symptoms. Iron therapy may 
be valuable for this population as their IDA may be associated with decreased iron absorption, 
increased iron demand and insufficient dietary intake	57. Furthermore, 93.6% (n=73) (Table 10) of 
male outpatients and 55.1 %  of female outpatients (n=167) (Table 10) over the age of 50 did not 
undergo iron testing within 1- year of their first Hgb test, which produced an anemic result (Hgb 
<110 g/L, low MCH and/or MCV). Older populations should also be considered as an important 
group where a missed opportunity for testing may have a significant impact on health outcomes. 
Occult bleeding originating from the gastrointestinal tract is one of the leading sources of IDA in 
post-menopausal women and men	61. Patients who are greater than 65 years of age with IDA 
should be screened for occult gastrointestinal cancers	57. There is evidence to suggest that older 
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adults with anemia have gastrointestinal cancer 31 times more frequently than adults without 
anemia	62 
 
5.3 Potential Approaches to Improve Utilization of Laboratory Test Bundles in Eastern 
Health  
 
 Improving test-ordering behaviours, particularly in a primary care setting may be an 
intricate task. There are a number of factors to take into consideration in the development of 
interventions to improve laboratory test utilization including but not limited to: patient 
expectations of their physician, physician training, feasibility of the intervention and the extent in 
which patient-practitioner priorities coincide. Primary care physicians have often completed their 
training and have already developed individual heuristics for test ordering, creating further 
difficulty in eliciting behaviour change	9.  Investigations have found that a high proportion of 
patients would like to undergo more laboratory testing in order to diagnose their illness	63. This 
highlights the importance of physician education to improve test utilization, improve quality of 
care and provide physicians with the necessary knowledge to explain to patients the impracticality 
of unnecessary testing. 
 
 While developing approaches to improve the utilization of these test bundles it is important 
to consider that there is a small body of literature, which specifically investigates the impact of 
interventions in the primary care setting. Many of these studies are considered to be of low 
methodological quality, impacting the external validity of the results	28. Additionally, these 
inquiries do not specifically investigate the effects of these actions on the two bundles of tests 
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analyzed in this thesis, introducing the notion that these interventions may not be appropriate for 
these specific tests	28. 
 
 The literature suggests that interventions involving restricted computerised ordering 
systems	31, computerised ordering systems with integrated cost display	19 or integrated decision-
making	25,26 may be effective in improving test ordering behaviours. However, general 
practitioners working within the Eastern Health region do not have a standardized computer 
ordering system, rendering these types of interventions impractical at this time.  
 
System based, order form restriction interventions were successful in altering test ordering 
behaviours, however their sustainability is challenged as they may only elicit superficial behaviour 
change	29,32-34.  Restricted order forms may not be the ideal intervention for altering test-ordering 
behaviours as they may limit appropriate test requests. The main focus of only reducing test 
ordering does not correspond to the purpose of the Quality of Care NL’s initiative, which is to 
ensure the right treatment is provided to the right patient at the right time14. However, this category 
of intervention may be practical for tests that may be considerably over-utilized (e.g. blood urea). 
Meng and colleagues	32 bypassed the risk of not providing the necessary care to patients due to a 
restricted order form by allowing general practitioners to order restricted tests following 
consultation with a clinical biochemist. 
 
 Based on the literature, an educational intervention would theoretically be the most 
effective in altering test-ordering behaviours for primary care settings in the Eastern Health Region 
while simultaneously preserving the goals of the Quality of Care NL’s initiative. Education-based 
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strategies have been found to be effective in improving test-ordering behaviours in primary care 
physicians	28.  Moreover, there is evidence in the literature to suggest that providing physicians 
with educational guidelines is relatively inexpensive and practical for a comprehensive 
implementation 64. The feasibility of intervention distribution is important, particularly in the 
Eastern Health Region due to its large geographical area 52. The sustainability of these 
interventions is scrutinized throughout the literature, however, Mindemark and colleagues	18 
provide evidence, although minimal, that test ordering behaviours remained improved 8-years post 
educational intervention. Educational-based interventions should incorporate multiple strategies 
(i.e. education and personalized performance feedback) and only target less than four tests for 
ordering behaviour modification 9. Educational feedback programs should be designed 
systematically while incorporating guidance from the literature	65. Implementing interventions to 
educate physicians to deliver high-value care is a difficult task and may be facilitated by providing 
effective knowledge translation, encouraging reflective practices and providing a supportive 
environment	66. 
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5.4 Undertaken Interventions to Improve Utilization in Eastern Health 
 
As a result of these investigations, interventions have been implemented throughout the 
Eastern Health Region to improve the utilization of tests described in this thesis. 
 
 Methods implemented within the region to reduce test utilization consisted of: (1) Audit & 
feedback to physicians through personalized report cards, (2) Academic detailing with knowledge 
translation, (3) system-based order form restriction. In addition to data analyzed in this thesis, 
more recent test ordering behaviours were taken into consideration and personalized report cards 
demonstrating physicians test-ordering behaviours compared to his/her peers were provided to all 
physicians through email. Academic detailing through knowledge translation consisted of a 
clinical specialist visiting physician’s practices and discussing test ordering behaviours and 
reviewing clinical scenarios where each test are indicated. The system-based intervention 
consisted of a restricted ordering form where blood urea was removed. As previously mentioned, a 
restricted order form may directly contradict Quality of Care NL’s initiative to ensure the right 
patient receives the right treatment at the right time. However, similar to Meng and colleagues	32, a 
clinical specialist who implemented the process change allowed physicians to request the test 
manually in a separate hand written request box to mitigate the risk of not providing the necessary 
care to patients when felt to be clinically indicated. The same solution was applied in Eastern 
Health. All three interventions were used to improve test ordering of the urea kidney function test. 
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Audit and personalized report cards and academic detailing through knowledge translation were 
used to improve ordering behaviour of iron status tests (serum ferritin). 
 
  As of June 2017, data would suggest that following the implementation of the three 
interventions to reduce serum urea ordering there has been a 62% reduction in the volume of urea 
clinical investigations being requested for outpatients within the Eastern Health Region since 
January 2015. This decrease has a produced an estimated annual cost avoidance in Eastern Health 
of $267, 220	67 (See figure 33). Furthermore, following implementation of the discussed 
intervention serum ferritin test ordering has undergone a 20% reduction, eliciting an estimated 
annual cost avoidance in Eastern Health of $159, 280 67 (See Figure 34).  
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Figure 33: Quality of Care NL Blood Urea Practice Point. This figured highlights that there has been a 62% reduction in urea 
testing ordered by general practitioners following the test being removed from the order form and academic detailing. The estimated 
cost avoidance is $267, 220 
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Figure 34: Quality of Care NL Iron Testing Practice Point. This figured highlights that there has been a 20% reduction in ferritin 
testing ordered by general practitioners following academic detailing. The estimated cost avoidance is $159, 280 
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5.5 Limitations 
In an attempt to minimize bias and to maintain the validity of the analysis, the initial total 
for tests ordered during the previously specified time period did not undergo data cleansing. This 
allowed for an accurate representation of the crude number of laboratory investigations being 
performed. Following this initial analysis, data cleansing required the removal of all tests that 
provided either no test result or a result that was believed to be inaccurate. Removed or edited test 
results typically occur when there is a sample quality problem or if there is an insufficient amount 
of the sample to complete the test.. This data cleaning process may have introduced bias into this 
investigation through the removal of data points due to absent or inconsistent values. The 
noteworthy numbers of removed tests during this process are as follows: 20, 239 (4.3% of total) 
Hgb, 3, 853 (4.5% of total) ferritin and 971 (4.1% of total) iron saturation tests. Taking this into 
consideration, it is believed that the impact of this limitation is minimal. The risk of bias is greatly 
mitigated by the large data set. The small alterations would have minimal impact on the pattern of 
test utilization portrayed by the data.  
 The foremost limitation of this investigation is that it does not take into consideration the 
specific clinical situation in which tests were ordered. Patient history, symptoms and test 
indication data pertaining to each ordered laboratory investigation were not included in this 
analysis. For this reason, the interpretation of the results is more difficult. Taking this into 
consideration, this investigation has the capacity to identify patterns of utilization and provide 
information to deduce areas of the health care system that may require further investigations to 
undergo improvement in terms of test ordering behaviour.  However, it does not provide certain 
evidence of inappropriate utilization for these bundles of tests.  
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5.6 Implications 
 
Our findings suggest that serum urea may be over-utilized independently and in 
combination with serum creatinine. It is also indicated that iron testing is potentially over and 
under used. General practitioners elicited the highest ordering rates for both tests and based on the 
literature an educational-based intervention in conjunction with personalized physician ordering 
feedback may be the most effective method for improving ordering behaviour for both bundles of 
tests. Serum urea ordering patterns may benefit from the implementation of a system-based, order 
form restriction.  
The information reported is useful for decision makers as it provides areas of concern for 
test ordering patterns. Additionally, the qualitative synthesis of the literature describes the 
appropriate clinical scenario that is indicated for the use of each test and methods used to improve 
laboratory test utilization in primary care settings. This information could serve as a tool for 
decision makers to guide the development of future interventions. This would ensure that the 
modification of test ordering behaviour would not be associated with a decrease in the quality of 
care provided by general practitioners, thereby maintaining the overarching goals of the Quality of 
Care NL’s initiative. It is important for decision makers to consider the impact of interventions on 
the clinical outcomes of patients, as there are minimal data available that consider the subsequent 
effects of test ordering	28. 
One novel aspect of this investigation is that it takes into consideration the result of the 
laboratory requests.  The majority of the literature, which investigates the utilization of laboratory 
investigations, focuses on the physician, with minimal consideration from the patients’ perspective 
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28.  Enhanced appropriateness of test ordering behaviours should be associated with improved 
clinical outcomes for patients	68. 
As previously acknowledged, a major limitation of this investigation is that it does not 
include data that pertains to the clinical situation in which the tests were ordered. There is a 
possibility that laboratory tests were indicated based on presenting patient symptoms and history. 
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